{"study_id": 49292, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether silver nanoparticles synthesized from Boswellia dalzielii stem bark extract could inhibit the proliferation of Kasumi-1 leukemia cells and induce cell cycle arrest.", "results_summary": "The synthesized silver nanoparticles demonstrated antioxidant capacity and effectively inhibited Kasumi-1 leukemia cell proliferation, with IC50 values of 49.5 \u03bcg/ml at 48 hours and 13.25 \u03bcg/ml at 72 hours. The nanoparticles also induced cell cycle arrest at the S and G2/M phases.", "population_specificity": "Kasumi-1 leukemia cells (in vitro study)", "effective_dosage": "49.5 \u03bcg/ml (48 hours), 13.25 \u03bcg/ml (72 hours)", "study_duration": "48 and 72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:41.103098+00:00"}
{"study_id": 49295, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the synergistic effects of Boswellia serrata combined with L-cysteine and whey protein on antioxidant properties, shelf life, and sensory characteristics of pork patties.", "results_summary": "The study found that Boswellia serrata, when combined with cysteine and whey protein (WBC treatment), significantly enhanced DPPH radical-scavenging activity, sensory characteristics, and reduced TBARS and MetMb values, indicating improved antioxidant effects and shelf life. The combination also improved water holding capacity and reduced cooking loss and hardness in pork patties.", "population_specificity": "Pork patties (in vitro food model)", "effective_dosage": "1% Boswellia serrata (combined with 2% whey and 0.25% cysteine)", "study_duration": "7-day storage period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:41.428662+00:00"}
{"study_id": 49294, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify and evaluate the antibacterial constituents of Boswellia dalzielii stem bark and validate its traditional use in treating bacterial infections.", "results_summary": "The study isolated 14 compounds, including dalzienoside (newly reported), and found that \u03b1-boswellic acid, \u03b2-boswellic acid, and acetyl-11-keto-\u03b2-boswellic acid exhibited strong antibacterial activity against multiple bacterial strains, with MIC values as low as 3.125 \u00b5g/mL. The crude extract and fractions also showed moderate to significant antibacterial effects.", "population_specificity": "Bacterial strains (Staphylococcus aureus, Salmonella typhi, Enterobacter cloacae, Streptococcus pneumoniae, Pseudomonas aeruginosa).", "effective_dosage": "MIC values: crude extract (250 \u00b5L/mL), fractions (7.8\u2013125 \u00b5g/mL), compounds (3.125 \u00b5g/mL).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:42.578504+00:00"}
{"study_id": 49297, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a herbal combination including Boswellia serrata could improve cognitive impairment and reduce oxidative brain damage in hypothyroid rats.", "results_summary": "The herbal combination, including Boswellia, significantly improved memory impairment, reduced oxidative damage markers, and enhanced antioxidant enzyme activity in the brain of hypothyroid rats. The effects were comparable to donepezil, a standard treatment for cognitive impairment.", "population_specificity": "Hypothyroid rats induced by propylthiouracil (PTU) administration.", "effective_dosage": "640 and 1,280 mg/kg of the herbal combination (including Boswellia) mixed with honey.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:43.407291+00:00"}
{"study_id": 49298, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining Boswellia serrata extract with bacterial nanocellulose (BNC) via nanoemulsions could overcome hydrophilicity challenges for effective anti-inflammatory skin treatment.", "results_summary": "The study found that nanoemulsions successfully incorporated Boswellia serrata extract into BNC without altering its key properties, demonstrated biphasic drug release, and confirmed biocompatibility ex ovo. Drug penetration into skin depended on nanoemulsion type, application frequency, and incubation time.", "population_specificity": "Not specified (ex ovo and porcine skin models used).", "effective_dosage": "Not specified.", "study_duration": "Storage stability tested over 30 days; intervention duration not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:45.006029+00:00"}
{"study_id": 49301, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antidiabetic effects and impact on glycoprotein metabolism of an aqueous extract of Boswellia ovalifoliolata stem bark in diabetic rats.", "results_summary": "Treatment with the extract significantly reduced fasting blood glucose, increased insulin and hemoglobin levels, and decreased glycosylated hemoglobin. It also lowered glycoprotein levels in plasma, liver, and kidney tissues.", "population_specificity": "Streptozotocin-induced diabetic rats", "effective_dosage": "200 mg/kg body weight", "study_duration": "40 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:48.852117+00:00"}
{"study_id": 49299, "supplement_id": 947, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness and safety of Boswellia serrata and its extracts in treating osteoarthritis (OA) symptoms compared to placebo or western medicine.", "results_summary": "Boswellia and its extracts significantly reduced pain, stiffness, and improved joint function in OA patients, with statistically significant results across multiple outcome measures. The study concluded that Boswellia is an effective and safe treatment option for OA.", "population_specificity": "Patients with osteoarthritis (545 participants across 7 trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "At least 4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:49.205366+00:00"}
{"study_id": 49300, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 50, "study_goal": "The researchers aimed to determine whether Boswellia serrata gum resin influences GAD65 autoantibodies, a marker associated with LADA (Latent Autoimmune Diabetes in Adults).", "results_summary": "The study found that Boswellia serrata gum resin treatment led to a 25% linear decrease in GAD65 autoantibodies over 9 months, suggesting potential benefits in preventing insulitis in LADA patients.", "population_specificity": "A male patient diagnosed with LADA and positive GAD65 autoantibodies.", "effective_dosage": "Not specified", "study_duration": "9 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:49.570448+00:00"}
{"study_id": 49302, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of SLBSP (a Boswellia extract) versus standardized BSE for treating symptomatic knee osteoarthritis, focusing on pain relief, functional improvement, and inflammatory cytokine modulation.", "results_summary": "Both SLBSP and BSE showed significant improvements in pain and function (WOMAC and VAS scores), with no statistically significant difference between them. SLBSP was superior in reducing the need for rescue analgesics and lowering pro-inflammatory cytokine levels compared to BSE.", "population_specificity": "Patients with symptomatic knee osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:50.314091+00:00"}
{"study_id": 49303, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Boswellia species and their main constituents, boswellic acids, as modulators of mechanisms involved in neurodegenerative diseases.", "results_summary": "The study found that Boswellia species exhibit neuroprotective effects through antioxidative, anti-inflammatory, antiamyloidogenic, and anti-apoptotic properties, supported by in vitro, animal, and clinical studies. These bioactive components may enhance cognitive activity and protect against neurodegeneration.", "population_specificity": "Not specified (includes in vitro, animal, and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:50.920355+00:00"}
{"study_id": 49304, "supplement_id": 947, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the testicular toxicity of standardized methanolic extract of Boswellia sacra oleo gum resin in rats through repeated oral dose administration.", "results_summary": "The extract did not cause significant behavioral, weight, or histological changes but significantly decreased serum testosterone levels at the highest dose (1000 mg/kg). Gene expression analysis revealed antioxidant potential, suggesting protective effects against toxicants.", "population_specificity": "Male rats", "effective_dosage": "Three doses (highest tested dose was 1000 mg/kg, orally)", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:51.979365+00:00"}
{"study_id": 49305, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of Boswellia serrata resin (BSR) supplementation in broiler chicken diets on fatty acid profiles in tissues and meat quality.", "results_summary": "BSR supplementation improved polyunsaturated fatty acid content in breast and drumstick muscles and abdominal fat, enhanced dietary parameters (n-3/n-6 ratio, saturation indices), and improved physicochemical properties like water-holding capacity and cooking losses. The color parameter a* decreased in breast muscles with higher BSR doses.", "population_specificity": "Ross 308 broiler chickens", "effective_dosage": "1.5%, 2%, and 2.5% of BSR in diet", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:54.080490+00:00"}
{"study_id": 49291, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to characterize the population structure of Boswellia papyrifera and prioritize conservation intervention alternatives using Analytical Hierarchy Process (AHP) modelling techniques.", "results_summary": "The study found that Boswellia papyrifera populations are unstable, with low density (266 trees ha-1), absence of regeneration, and saplings due to overgrazing, over-tapping, pests, agricultural expansion, and poor management. The AHP analysis identified area exclosure with medium (AEMTR) and long (AELTR) tapping resting periods as the best conservation strategies.", "population_specificity": "Boswellia papyrifera woodlands in the Abergele district, northern Ethiopia.", "effective_dosage": "Not available", "study_duration": "Not applicable (conservation study, not an intervention trial)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:56.226092+00:00"}
{"study_id": 49309, "supplement_id": 947, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of repeated administration of Boswellia sacra extract on liver and kidney functions in rats, assessing sub-chronic toxicity.", "results_summary": "The study found no significant behavioral toxicity, changes in food consumption, or weight gain. Biomarkers and histological examination indicated safety at tested doses, with only a dose-dependent increase in serum total protein levels.", "population_specificity": "Rats", "effective_dosage": "Up to 100 mg/kg body weight", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:58.049391+00:00"}
{"study_id": 49310, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether pharmacokinetic interactions occur among the major constituents of Boswellia serrata extract and other supplements when administered alone or in combination.", "results_summary": "The study found no significant differences in the pharmacokinetic profiles of Boswellia's constituents when administered in combination with other supplements compared to when administered alone, suggesting no pharmacokinetic interactions.", "population_specificity": "16 healthy participants", "effective_dosage": "Not specified", "study_duration": "Single-dose administration with 1-week washout between treatments", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:58.572165+00:00"}
{"study_id": 49308, "supplement_id": 947, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the efficacy and safety of a transrectal association of Boswellia resin extract and propolis-derived polyphenols for relieving prostatitis-like symptoms.", "results_summary": "The study found that the Boswellia-propolis combination significantly reduced genitourinary pain and improved quality of life, with a 28.5% reduction in pain domain scores and no significant adverse events reported.", "population_specificity": "Men aged \u226518 with chronic/recurrent prostatitis-like symptoms persisting for at least 3 of the last 6 months.", "effective_dosage": "1 suppository containing Boswellia resin extract and propolis-derived polyphenols, once daily.", "study_duration": "20 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:58.856067+00:00"}
{"study_id": 49306, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antioxidant, anti-inflammatory, and anti-fibrotic effects of Boswellia serrata gum resin against CCl4-induced liver damage in rats.", "results_summary": "Boswellia significantly reduced liver damage markers (AST, ALT, LDH), restored bilirubin, triglyceride, and albumin levels, alleviated oxidative stress, and lowered inflammatory markers (TNF-\u03b1, NF-\u03baB, TGF-\u03b2, IL-6, COX-2). It also exhibited antifibrotic activity in histopathological analysis.", "population_specificity": "Rats with CCl4-induced liver fibrosis.", "effective_dosage": "Not specified", "study_duration": "Two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:59.781185+00:00"}
{"study_id": 49307, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anti-inflammatory activities of bioactive compounds in purified fractions of Boswellia serrata, specifically focusing on leukotriene and COX-2 inhibition in vitro and lung inflammation reduction in vivo.", "results_summary": "The study found that Boswellia serrata ethanolic extracts significantly reduced leukotriene-C4-synthase (52%), leukotriene-A4-hydrolase (22%), and COX-2 (99%) activities in vitro. In vivo, oral administration reduced OVA-induced lung inflammation by ~51% in mice, though less effectively than dexamethasone (~66%).", "population_specificity": "Human leukemia (HL-60) cells and OVA-sensitized BALB/c mice.", "effective_dosage": "50 mg/kg and 100 mg/kg body weight (oral administration).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:00.100188+00:00"}
{"study_id": 49311, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Proxelan\u00ae (Boswellia) monotherapy on pain symptoms in patients with chronic prostatitis or chronic pelvic pain syndrome.", "results_summary": "Proxelan\u00ae monotherapy significantly reduced pain symptoms, urinary symptoms, and improved quality of life. It also decreased IL6 levels and increased sperm motility, though leukocytospermia persisted in some patients.", "population_specificity": "Men under 50 with chronic prostatitis/chronic pelvic pain syndrome, no urinary obstruction, PSA <4 ng/mL, and negative microbiology tests.", "effective_dosage": "1 suppository daily at bedtime.", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:01.131828+00:00"}
{"study_id": 49312, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the concentrations of AKBA and KBA in human and canine Boswellia serrata extract (BSE) formulations and compare them to label claims.", "results_summary": "The study found large variations in AKBA and KBA concentrations across market formulations, with products claiming AKBA containing significantly higher levels. Label claims for AKBA were exceeded, but KBA was undetectable in some products.", "population_specificity": "Canine and human Boswellia serrata extract formulations.", "effective_dosage": "Not specified (concentrations measured in mg/g AF).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:03.060518+00:00"}
{"study_id": 49315, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the anti-arthritic activity of Boswellia serrata extract (BSE) in rats with induced rheumatoid arthritis (RA).", "results_summary": "BSE at 180 mg/kg showed significant improvement in body weight, reduced ankle diameter and arthritic index, but no significant change in paw volume or TNF-\u03b1 levels. Histopathological results indicated reduced inflammation.", "population_specificity": "Wistar rats with CFA-induced arthritis.", "effective_dosage": "180 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:07.087107+00:00"}
{"study_id": 49314, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Boswellia serrata resin extract could improve motor dysfunction and reduce oxidative stress in a rat model of Parkinson's disease.", "results_summary": "Boswellia extract significantly reduced motor impairments (rotational behavior and narrow beam test performance) in rats with induced Parkinson's disease, though oxidative stress markers showed no significant changes. The effects were dose-dependent, with 125 mg/kg and 250 mg/kg showing the most consistent improvements.", "population_specificity": "Male rats with induced Parkinson's disease (intrastriatal 6-OHDA model).", "effective_dosage": "125 mg/kg, 250 mg/kg, and 500 mg/kg (administered for 3 weeks).", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:07.939116+00:00"}
{"study_id": 49313, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a method for quantifying boswellic and lupeolic acids in Boswellia species and evaluate their cytotoxic effects against a treatment-resistant breast cancer cell line.", "results_summary": "The study developed a sensitive HPLC-MS/MS method to analyze triterpenic acids in Boswellia oleogum resins, identifying species-specific and geographic variations in composition. Extracts, particularly from B. sacra, showed potent cytotoxicity against MDA-MB-231 breast cancer cells, with efficacy correlating with triterpenic acid content.", "population_specificity": "Human metastatic breast cancer cell line MDA-MB-231 (in vitro study).", "effective_dosage": "Not specified (IC50 for B. sacra extract was 8.3 \u00b1 0.6 \u00b5g/mL).", "study_duration": "Not specified (in vitro assay).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:08.107806+00:00"}
{"study_id": 49316, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the antibacterial effects of Boswellia serrata hydroalcoholic extract against Aggregatibacter actinomycetemcomitans, a periodontal pathogen.", "results_summary": "Boswellia serrata hydroalcoholic extract showed antimicrobial activity against A. actinomycetemcomitans, with a minimum inhibitory concentration (MIC) of 1666 \u03bcg/mL, though significantly less effective than chlorhexidine (3.33 \u03bcg/mL).", "population_specificity": "In vitro study (bacterial culture of A. actinomycetemcomitans).", "effective_dosage": "1666 \u03bcg/mL (MIC).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:08.108999+00:00"}
{"study_id": 49318, "supplement_id": 947, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of a standardized Boswellia serrata extract (BSE) containing AKBBA and BBA in improving physical function and reducing inflammation in patients with knee osteoarthritis.", "results_summary": "BSE significantly improved physical function, reduced pain and stiffness, and decreased inflammatory markers compared to placebo. Radiographic assessments confirmed improved joint gap and reduced osteophytes, with no serious adverse events reported.", "population_specificity": "48 patients with osteoarthritis of the knee.", "effective_dosage": "Not specified in the abstract.", "study_duration": "120 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:08.461545+00:00"}
{"study_id": 181506, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a dietary supplement containing Boswellia on persistent knee discomfort in healthy subjects.", "results_summary": "The abstract does not provide specific results regarding Boswellia's effects.", "population_specificity": "Healthy subjects aged 40 years and older with persistent knee discomfort (pain intensity > 3 on a 1-10 cm VAS).", "effective_dosage": "Not available", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:09.041277+00:00"}
{"study_id": 49317, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the wound healing potential and mechanism of action of Boswellia serrata extract in a diabetic foot ulcer model.", "results_summary": "Boswellia serrata (200 and 400 mg/kg) significantly improved wound contraction, reduced oxidative-inflammatory markers, increased collagen synthesis and angiogenesis, and inhibited apoptosis in diabetic rats.", "population_specificity": "Sprague-Dawley rats with streptozotocin-induced diabetes.", "effective_dosage": "100, 200, and 400 mg/kg orally.", "study_duration": "16 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:09.703931+00:00"}
{"study_id": 181510, "supplement_id": 947, "safety_score": "70", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a supplement combination containing Boswellia serrata extract, among other ingredients, could effectively reduce hand pain in people with hand osteoarthritis compared to placebo.", "results_summary": "The study found no significant difference in pain reduction between the supplement combination group (which included Boswellia) and the placebo group over 12 weeks. Adverse event-related discontinuations were slightly higher in the supplement group (10%) compared to placebo (7%).", "population_specificity": "Adults aged over 40 with symptomatic hand osteoarthritis (radiographically confirmed, Kellgren Lawrence grade \u2265 2), predominantly women (81%).", "effective_dosage": "Boswellia serrata extract 250 mg/day (as part of a multi-ingredient supplement).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:13.507993+00:00"}
{"study_id": 181515, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize the safety, herb-drug interactions, and appropriate uses of Boswellia in the oncology setting based on literature reviews.", "results_summary": "The abstract does not provide specific findings about Boswellia's effects, only noting its popularity among searched supplements and the general lack of well-designed studies in cancer patients.", "population_specificity": "Cancer patients (oncology setting)", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:15.769297+00:00"}
{"study_id": 181516, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether current research on Boswellia provides sufficient evidence to inform decisions for practice and self-care, specifically for chronic musculoskeletal pain in Special Operations Forces personnel.", "results_summary": "The study found insufficient strong research on Boswellia to make any recommendations for its use as a supplement for chronic musculoskeletal pain. No conclusions were drawn due to low-quality evidence.", "population_specificity": "Special Operations Forces personnel with chronic musculoskeletal pain.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:16.136721+00:00"}
{"study_id": 181512, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the efficacy of Acidif plus\u00ae (containing Boswellia serrata) in treating uncomplicated UTIs in women compared to standard antibiotic therapy.", "results_summary": "Acidif plus\u00ae was found non-inferior to fosfomycin, with over 50% of patients symptom-free and 85% showing bacterial elimination in urine cultures post-treatment. It was more effective than fosfomycin in symptom alleviation and bacterial clearance.", "population_specificity": "Women with uncomplicated UTIs (symptomatic or asymptomatic, bacteriuria-positive).", "effective_dosage": "2 tablets per day (1 morning, 1 evening) for 7 days.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:17.019105+00:00"}
{"study_id": 181513, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the efficacy of a supplement combination, including Boswellia, for treating symptomatic hand osteoarthritis compared to placebo.", "results_summary": "The abstract does not provide specific results regarding Boswellia's effects, as it describes the study protocol rather than outcomes.", "population_specificity": "Adults aged over 40 with painful hand osteoarthritis and structural changes on X-ray (Kellgren and Lawrence grade \u22652).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:17.278869+00:00"}
{"study_id": 181520, "supplement_id": 947, "safety_score": "80", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to summarize existing evidence and recommendations supporting the use of Boswellia serrata extract for osteoarthritis (OA) symptom relief.", "results_summary": "Limited research evidence supports the oral use of Boswellia serrata extract for OA, though the available studies were of poor quality. The products were generally recognized as safe, but few studies adequately reported adverse effects.", "population_specificity": "People with osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:17.808868+00:00"}
{"study_id": 181519, "supplement_id": 947, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the long-term efficacy and safety of a lecithin-based delivery form of Boswellia serrata (Casperome\u00ae) for preventing symptoms in otherwise healthy subjects with mild irritable bowel syndrome (IBS).", "results_summary": "The Boswellia group showed lower mean scores for IBS symptoms, reduced need for rescue medications, and fewer medical consultations compared to the standard management group. Oxidative stress was significantly decreased in Boswellia-supplemented subjects, and adverse events were minimal.", "population_specificity": "Otherwise healthy participants with mild IBS (69 subjects).", "effective_dosage": "One tablet/day (Casperome\u00ae).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:18.099457+00:00"}
{"study_id": 181521, "supplement_id": 947, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Casperome\u00ae, a lecithin-based Boswellia serrata extract, in treating musculoskeletal disorders such as Achilles tendonitis, epicondylitis, and sport injuries.", "results_summary": "Casperome\u00ae demonstrated prompt pain reduction, improved functionality, and reduced inflammatory markers without significant adverse effects. Clinical studies, including randomized designs, consistently supported its efficacy in musculoskeletal conditions.", "population_specificity": "Patients with musculoskeletal disorders (e.g., Achilles tendonitis, epicondylitis, radiculopathies, ankle sprains, sport injuries).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:18.945010+00:00"}
{"study_id": 181522, "supplement_id": 947, "safety_score": "100", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of a food supplement containing Boswellia serrata extracts as an alternative or adjuvant treatment for symptomatic UTIs in pregnancy.", "results_summary": "The food supplement showed significant efficacy, with 70.0% of treated patients achieving negative urine cultures at 7 days, compared to 43.2% in the control group. Symptoms disappeared in 62.5% of treated patients, and no side effects were reported.", "population_specificity": "Pregnant women with symptomatic cystitis.", "effective_dosage": "Not specified.", "study_duration": "1 week (with an optional additional week for some patients).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:22.895984+00:00"}
{"study_id": 181525, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to assess the evidence for dietary supplements, including Boswellia, in managing inflammatory bowel disease (IBD).", "results_summary": "The abstract does not provide specific findings regarding Boswellia's effects on IBD.", "population_specificity": "IBD patients (no specific subgroup mentioned for Boswellia).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:24.459687+00:00"}
{"study_id": 181524, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementation with curcumin and Boswellia serrata extract (BSE) could reduce glycoxidation and lipid peroxidation in chronically exercising master athletes.", "results_summary": "The study found that the curcumin/BSE group showed a significant decline in total AGEs, while both groups experienced reductions in sRAGE, NEFA, and MDA. Only the changes in total AGE and MDA differed significantly between the curcumin/BSE and MD groups.", "population_specificity": "Healthy male athletes engaged in chronic intensive exercise.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:25.021097+00:00"}
{"study_id": 181526, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize current literature on the efficacy and adverse effects of Boswellia serrata as a dietary supplement for treating inflammatory bowel disease (IBD).", "results_summary": "The abstract does not provide specific findings on Boswellia's effects, but it indicates that the review includes an evaluation of its efficacy and adverse effects for IBD treatment.", "population_specificity": "Patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:25.718385+00:00"}
{"study_id": 181523, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of a supplement containing Boswellia serrata and curcumin on eicosanoid derivatives in early-stage chronic kidney disease (CKD) patients.", "results_summary": "The study found a significant group effect for prostaglandin E (PGE) and a trend for a Group \u00d7 Time interaction, suggesting potential anti-inflammatory effects of the supplement in early-stage CKD patients.", "population_specificity": "Patients with stage 2 and stage 3 CKD who had not initiated hemodialysis (n=16, mean age 56.0 \u00b1 16.0 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:26.168494+00:00"}
{"study_id": 181528, "supplement_id": 947, "safety_score": "85", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess whether a herbal supplement containing Boswellia serrata and Curcuma longa could reduce systemic inflammation and improve antioxidant status in non-dialysis CKD patients.", "results_summary": "The study found a significant reduction in IL-6 levels, indicating potential anti-inflammatory effects, but no significant changes in TNF-\u03b1, CRP, or GPx. The supplement was deemed safe and tolerable.", "population_specificity": "Non-dialysis chronic kidney disease (CKD) patients (n=16, mean age 56.0\u00b116.0 yrs).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:27.104609+00:00"}
{"study_id": 181527, "supplement_id": 947, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if a dietary supplement containing Boswellia serrata and Curcuma longa could reduce postoperative pain in patients undergoing arthroscopic supraspinatus tendon repair.", "results_summary": "The supplement significantly reduced pain at 1 week post-surgery compared to placebo, with modest effects at 2 weeks, but no significant differences in long-term pain. Patient global assessment scores were good across all subjects.", "population_specificity": "Patients with full-thickness supraspinatus tendon tears treated by arthroscopy.", "effective_dosage": "Not specified (referred to as Tendisulfur\u00ae).", "study_duration": "2 months (3 weeks pre-surgery and continued post-surgery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:27.261068+00:00"}
{"study_id": 5167, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could effectively resolve vascular failure, prolonged bleeding, and defect widening in surgically perforated stomach lesions in rats, and to explore its mechanisms of action.", "results_summary": "BPC-157 rapidly restored blood vessel function, reduced bleeding, contracted defects, and promoted advanced healing with fewer adhesions, while also normalizing malondialdehyde and nitric oxide levels and influencing gene expression related to healing pathways.", "population_specificity": "Rats with surgically perforated stomach lesions.", "effective_dosage": "0.01 \u03bcg/kg administered as an abdominal bath.", "study_duration": "Immediate effects observed within 1-15 minutes post-injury; healing assessed at day 1 and day 7.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:29.562257+00:00"}
{"study_id": 5168, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the effects of isoprenaline-induced myocardial infarction and multiorgan failure in rats.", "results_summary": "BPC-157 reduced necrosis markers, attenuated organ damage, and improved cardiac function by decreasing oxidative stress and maintaining NO system function. It also counteracted the harmful effects of the NOS-blocker L-NAME.", "population_specificity": "Rats treated with isoprenaline to induce myocardial infarction and multiorgan failure.", "effective_dosage": "10 ng/kg and 10 \u00b5g/kg intraperitoneally.", "study_duration": "Assessed at 24 hours post-intervention.", "interactions": "Counteracted the noxious effect of L-NAME (NOS-blocker).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:31.903408+00:00"}
{"study_id": 5170, "supplement_id": 948, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's ability to counteract venous occlusion-induced syndromes, including ischemia-reperfusion injury and Budd-Chiari syndrome, and its cytoprotective effects.", "results_summary": "BPC-157 demonstrated effectiveness in resolving major vessel occlusion disturbances, maintaining endothelium and epithelium, and stabilizing membranes. It showed therapeutic potential in ulcerative colitis and multiple sclerosis trials, with no reported lethal dose.", "population_specificity": "Not specified (generalized from in vitro and animal models, with references to human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:32.866291+00:00"}
{"study_id": 5175, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate BPC-157 as a potential prophylactic and complementary treatment for COVID-19, focusing on its anti-inflammatory, cytoprotective, and endothelial-protective effects.", "results_summary": "BPC-157 demonstrated anti-inflammatory, cytoprotective, and endothelial-protective effects in animal models, improving vascular integrity, immune response, and reducing proinflammatory profiles. The peptide's activation of eNOS and NO release was associated with tissue repair and angiomodulatory properties.", "population_specificity": "Animal models (species not specified)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:35.926480+00:00"}
{"study_id": 5172, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the harmful effects of abdominal compartment syndrome by improving venous function and activating collateral pathways.", "results_summary": "BPC-157 administration reversed multiple adverse effects of intra-abdominal hypertension, including venous and arterial thrombosis, organ congestion, and severe ECG disturbances, while restoring failed collateral pathways and preventing tissue damage. Microscopic analysis confirmed reduced hyperemia, congestion, and structural damage in multiple organs.", "population_specificity": "Thiopental- and esketamine-anesthetized rats with induced abdominal compartment syndrome.", "effective_dosage": "10 \u00b5g or 10 ng/kg, administered subcutaneously.", "study_duration": "Single dose administered after 10 minutes of induced hypertension.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:36.267715+00:00"}
{"study_id": 5173, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of BPC-157 on healing a myotendinous junction defect in rats, which does not heal spontaneously.", "results_summary": "BPC-157 demonstrated significant therapeutic effects, including improved macroscopic and microscopic healing, biomechanical and functional recovery, reduced oxidative stress, and normalized eNOS and COX-2 mRNA levels. Treated rats showed complete defect resolution and no inflammatory infiltrate by 28-42 days.", "population_specificity": "Rats with surgically induced myotendinous junction defects.", "effective_dosage": "10 \u00b5g/kg and 10 ng/kg intraperitoneally; 0.16 \u00b5g/mL and 0.16 ng/mL orally in drinking water (12 mL/rat/day).", "study_duration": "Up to 42 postoperative days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:36.610185+00:00"}
{"study_id": 5174, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the severe occlusive-like syndrome and multi-organ dysfunction induced by high-dose lithium in rats.", "results_summary": "BPC-157 effectively counteracted lithium-induced syndromes, including intracranial and portal hypertension, aortal hypotension, thrombosis, and multi-organ damage, while attenuating oxidative stress and improving vascular and organ function.", "population_specificity": "Rats subjected to high-dose lithium sulfate (500 mg/kg/day, ip, for 3 days).", "effective_dosage": "Not specified for BPC-157 (only lithium dosage provided).", "study_duration": "3 days (lithium administration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:36.756080+00:00"}
{"study_id": 5176, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cytoprotective effects of BPC-157 in counteracting alcohol-induced systemic damage, including gastric lesions, vascular congestion, and organ injuries.", "results_summary": "BPC-157 rapidly reversed alcohol-induced damage, including brain swelling, vascular congestion, and organ lesions, while improving collateral blood flow and mitigating microscopic tissue damage.", "population_specificity": "Animal models (specific species not mentioned)", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg, administered intraperitoneally 1 minute after alcohol", "study_duration": "Acute intervention (single dose)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:39.050597+00:00"}
{"study_id": 5178, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of BPC-157 supplementation on biochemical and immunological parameters in honeybees, focusing on physiological changes and immune response.", "results_summary": "BPC-157 administration led to positive physiological changes in honeybees, including enhanced enzymatic activity (LAP) in mid-guts and improved immune markers, compared to control groups.", "population_specificity": "Newly emerged worker honeybees in laboratory-controlled conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:42.060874+00:00"}
{"study_id": 5177, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of BPC-157 in healing vesicovaginal fistulas and preventing bladder stone formation in rats with delayed treatment initiation.", "results_summary": "BPC-157 therapy reversed poor healing, stopped urinary leakage, improved tissue regeneration (epithelization, collagenization, granulation, neovascularization), reduced inflammation and necrosis, and prevented stone formation, with both \u00b5g and ng regimens showing efficacy.", "population_specificity": "Rats with well-formed 2-week vesicovaginal fistulas.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg, administered intraperitoneally once daily or orally in drinking water.", "study_duration": "Until sacrifice (exact duration not specified, but outcomes were assessed up to 6 weeks post-therapy initiation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:43.304863+00:00"}
{"study_id": 5182, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could activate alternative vascular pathways and counteract the effects of occluded superior mesenteric vessels in rats.", "results_summary": "BPC-157 rapidly activated collateral vascular pathways, counteracted hypertension and hypotension, reduced thrombosis, attenuated organ lesions, and decreased oxidative stress in multiple tissues.", "population_specificity": "Rats with occluded superior mesenteric vein and artery.", "effective_dosage": "10 \u00b5g/kg and 10 ng/kg, administered intraperitoneally.", "study_duration": "Assessments performed for 30 minutes post-ligation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:44.821240+00:00"}
{"study_id": 5180, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of BPC-157 on central nervous system disorders, including stroke, schizophrenia-like symptoms, and spinal cord injury, focusing on its role in the gut-brain axis.", "results_summary": "BPC-157 demonstrated significant therapeutic effects in counteracting stroke-induced brain damage, resolving schizophrenia-like symptoms, and promoting recovery from spinal cord injury by reducing inflammation and improving nerve function. It also modulated gene expression in hippocampal tissues and addressed dopamine and nitric oxide-system disturbances.", "population_specificity": "Rats (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:44.950409+00:00"}
{"study_id": 5179, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the effects of irremovable occlusion of the superior mesenteric vein and associated multiorgan dysfunction in rats.", "results_summary": "BPC-157 rapidly activated collateral blood flow pathways, restored venous connections, and counteracted hypertension, hypotension, thrombosis, and organ damage, while reducing oxidative stress.", "population_specificity": "Rats with induced superior mesenteric vein occlusion.", "effective_dosage": "10 \u00b5g/kg and 10 ng/kg, administered intraperitoneally.", "study_duration": "Assessments were conducted for 30 minutes post-ligation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:44.960607+00:00"}
{"study_id": 5171, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could prevent or reverse glaucoma-like symptoms induced by episcleral vein cauterization in rats.", "results_summary": "BPC-157 normalized intraocular pressure, preserved ganglion cells and optic nerve integrity, and counteracted retinal and choroidal vessel irregularities in rats with induced glaucoma. Both prophylactic and curative treatments showed positive effects.", "population_specificity": "Rats with induced glaucoma-like symptoms via episcleral vein cauterization.", "effective_dosage": "0.4 \u00b5g/eye, 0.4 ng/eye (local drops); 10 \u00b5g/kg, 10 ng/kg (intraperitoneal); 0.16 \u00b5g/mL, 0.16 ng/mL (oral, in drinking water).", "study_duration": "Six weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:46.105390+00:00"}
{"study_id": 5181, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could prevent and counteract monocrotaline-induced pulmonary arterial hypertension and cor pulmonale in rats.", "results_summary": "BPC-157 effectively counteracted monocrotaline-induced pulmonary arterial hypertension, including reversing disturbed parameters, preventing disease progression, and eliminating advanced pulmonary hypertension. Consistent beneficial effects were observed across all treatment regimens.", "population_specificity": "Rats with monocrotaline-induced pulmonary arterial hypertension.", "effective_dosage": "10 \u03bcg/kg or 10 ng/kg, administered once daily intraperitoneally or continuously in drinking water.", "study_duration": "Days 1-14, days 1-30 (early regimens), or days 14-30 (delayed regimen).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:47.254222+00:00"}
{"study_id": 5183, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to determine whether intra-articular injection of BPC-157, alone or combined with TB4, could relieve knee pain in a primary care setting.", "results_summary": "The study found that 91.6% of patients receiving BPC-157 alone and 75% of those receiving BPC-157 + TB4 reported significant improvement in knee pain, with an overall 87.5% response rate. No functional or quality-of-life metrics were assessed.", "population_specificity": "17 patients (16 surveyed) with various knee pain causes, treated at the Institute for Hormonal Balance in Orlando, Florida.", "effective_dosage": "Not specified", "study_duration": "Single injection, follow-up at 6 months to 1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:49.530678+00:00"}
{"study_id": 5184, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's effectiveness in wound healing across various tissue types and its potential to counteract bleeding disorders and thrombosis.", "results_summary": "BPC-157 demonstrated potent wound healing effects by resolving vessel constriction, stabilizing platelet plugs, and improving clot resolution. It also showed efficacy in preventing or attenuating arterial and venous thrombosis and aiding in ischemia/reperfusion scenarios.", "population_specificity": "Rats with various wound types (cutaneous, colocutaneous, gastrocutaneous, etc.) and induced bleeding disorders.", "effective_dosage": "Same dose range and equipotent routes across all injuries (specific dosage not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:51.391582+00:00"}
{"study_id": 5187, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract multiple organ dysfunction syndrome in rats with permanent occlusion of the superior mesenteric artery.", "results_summary": "BPC-157 rapidly recruited collateral vessels, improved blood flow, attenuated hypertension and hypotension, mitigated ECG disturbances, reduced thrombosis, and largely attenuated multiple organ lesions and disturbances.", "population_specificity": "Rats with permanent occlusion of the superior mesenteric artery.", "effective_dosage": "10 \u00b5g/kg and 10 ng/kg, administered via abdominal bath.", "study_duration": "1-minute ligation time.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:53.192426+00:00"}
{"study_id": 5188, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could protect against Clopidogrel-induced gastric injury by reducing inflammation, apoptosis, and promoting angiogenesis.", "results_summary": "BPC-157 attenuated Clopidogrel-induced gastric mucosal damage by inhibiting ER stress-mediated apoptosis and inflammation while promoting angiogenesis via VEGF-A/VEGFR1-mediated AKT/p38/MAPK pathways. NO blockade weakened BPC-157's protective effects.", "population_specificity": "Sprague Dawley rats with acetic acid-induced gastric ulcers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "L-NAME (NO blockade) weakened BPC-157's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:53.522374+00:00"}
{"study_id": 5185, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could mitigate the effects of superior sagittal sinus occlusion and associated multi-organ damage in rats.", "results_summary": "BPC-157 rapidly reduced brain swelling, normalized vascular pressures, and improved organ function, demonstrating efficacy in both central and peripheral recovery pathways. The peptide was effective even when administered at delayed time points post-occlusion.", "population_specificity": "Rats with induced superior sagittal sinus occlusion and multi-organ lesions.", "effective_dosage": "10 \u00b5g/kg and 10 ng/kg, administered intraperitoneally, intragastrically, or topically at various time points (1 min, 15 min, 24 h, 48 h post-ligation).", "study_duration": "Variable, with assessments made at multiple time points up to 48 hours post-ligation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:53.852835+00:00"}
{"study_id": 5186, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract retinal ischemia induced by L-NAME in rats by interacting with the NO-system.", "results_summary": "BPC-157 effectively reversed L-NAME-induced retinal ischemia, restoring normal eye background, choroidal blood vessels, and retinal thickness, while also improving behavioral presentation. The effects were observed whether administered 20 minutes or 48 hours after L-NAME.", "population_specificity": "Rats with induced retinal ischemia via L-NAME.", "effective_dosage": "10 \u03bcg (10 ng/kg) retrobulbar application (1 \u03bcg/0.1 ml saline per eye).", "study_duration": "4 weeks (with assessments at 1, 2, and 4 weeks).", "interactions": "Counteracted adverse effects of L-NAME.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:54.698730+00:00"}
{"study_id": 5189, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could attenuate bowel adhesion formation and improve vascular recovery in rats with parietal peritoneum excision, compared to NO-agents.", "results_summary": "BPC-157 promoted rapid vascular recovery and significantly reduced adhesion formation, even when administered post-treatment. Unlike NO-agents, which had mixed effects, BPC-157 consistently decreased NO- and MDA levels and improved outcomes.", "population_specificity": "Rats with parietal peritoneum excision and underlying muscle tissue damage.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg, administered once as an abdominal bath or intraperitoneally once daily.", "study_duration": "Up to 14 days, with post-treatment starting at day 7.", "interactions": "Maintained beneficial effects when co-administered with NO-agents (L-NAME, L-arginine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:56.409295+00:00"}
{"study_id": 5190, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic effects of BPC-157 on hippocampal ischemia/reperfusion injuries in rats, focusing on neural damage recovery and functional outcomes.", "results_summary": "BPC-157 counteracted early and delayed neural hippocampal damage, achieving full functional recovery in memory, locomotion, and coordination. Gene expression studies showed elevated levels of beneficial genes (e.g., Egr1, Akt1) and decreased levels of harmful genes (e.g., Nos2, Nfkb).", "population_specificity": "Male Wistar rats with bilateral clamping of the common carotid arteries.", "effective_dosage": "10 \u00b5g/kg applied as a 1 ml bath directly to the operated area.", "study_duration": "Intervention applied at 30 seconds post-clamping, with outcomes assessed at 24 and 72 hours of reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:05:57.686093+00:00"}
{"study_id": 5192, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the healing effects of BPC-157 on gastrointestinal fistulas and its broader therapeutic potential in wound healing and gastrointestinal integrity.", "results_summary": "BPC-157 demonstrated consistent healing of various gastrointestinal fistulas (both external and internal) and improved outcomes in impaired gastrointestinal anastomoses, even in the presence of NSAIDs, cysteamine, and other complicating factors. It also showed efficacy in healing diverse wounds, including ulcers, without achieving LD1.", "population_specificity": "Rats with gastrointestinal fistulas and impaired anastomoses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:00.492229+00:00"}
{"study_id": 5191, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the damage caused by the Pringle maneuver (portal triad obstruction) in rats, both during ischemia and reperfusion.", "results_summary": "BPC-157 effectively mitigated ECG disturbances, improved hemodynamics, reduced thrombosis, and attenuated organ damage (lung, liver, intestine, spleen, and heart) caused by ischemia-reperfusion injury in rats. It also promoted rapid collateral vessel recruitment to bypass occlusions.", "population_specificity": "Deeply anesthetized rats subjected to 30-minute portal triad clamping followed by 15-minute or 24-hour reperfusion.", "effective_dosage": "10 \u00b5g or 10 ng/kg, administered as a single challenge at various time points (before/during ischemia or during reperfusion).", "study_duration": "Single administration, with effects monitored over 15 minutes or 24 hours post-reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:01.223125+00:00"}
{"study_id": 5193, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether BPC-157 could resolve Budd-Chiari syndrome in rats by bypassing inferior vena cava occlusion and improving recovery.", "results_summary": "BPC-157 rapidly activated bypass pathways, counteracted hypertension and hypotension, reduced thrombosis, and improved organ pathology while maintaining normal liver nitric oxide and malondialdehyde levels.", "population_specificity": "Rats with suprahepatic occlusion of the inferior vena cava.", "effective_dosage": "10 \u00b5g/kg or 10 ng BPC 157, administered once.", "study_duration": "Single administration at 1 min, 15 min, 24 h, or 48 h post-ligation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:02.048306+00:00"}
{"study_id": 5194, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the inhibitory effects of antithrombotic agents (aspirin, clopidogrel, cilostazol) on platelet aggregation in rats.", "results_summary": "BPC-157 effectively counteracted the inhibitory effects of aspirin, clopidogrel, and cilostazol on platelet aggregation induced by arachidonic acid, ADP, collagen, and arachidonic acid/PGE1, but had no effect on extrinsic/intrinsic hemostasis or fibrin clot parameters.", "population_specificity": "Rats", "effective_dosage": "10 \u03bcg/kg, intragastrically, once daily", "study_duration": "3 days", "interactions": "Counteracted effects of aspirin, clopidogrel, and cilostazol on platelet aggregation", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:02.797691+00:00"}
{"study_id": 5196, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of BPC-157 on spinal cord injury recovery in a rat model, focusing on functional and histological improvements.", "results_summary": "BPC-157 treatment led to consistent clinical improvement, better motor function, reduced spasticity, and counteracted microscopic damage such as vacuole formation, axon loss, and edema. Functional rescue was observed across all stages of secondary injury.", "population_specificity": "Rat model with induced spinal cord injury (L2-L3 laminectomy and compression).", "effective_dosage": "200 or 2 \u03bcg/kg, single intraperitoneal injection.", "study_duration": "Assessments up to 360 days post-injury.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:03.480169+00:00"}
{"study_id": 5195, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could attenuate cyclophosphamide-induced hemorrhagic cystitis and its interaction with NO-system modulators (L-arginine and L-NAME).", "results_summary": "BPC-157 significantly reduced cyclophosphamide-induced bladder lesions, inflammation, and functional impairments, both alone and in combination with L-arginine or L-NAME, suggesting a NO-related mechanism.", "population_specificity": "Rats with cyclophosphamide-induced hemorrhagic cystitis.", "effective_dosage": "10 \u03bcg/kg/day or 10 ng/kg/day, intraperitoneally or orally in drinking water.", "study_duration": "Administered after cyclophosphamide induction (3-day cyclophosphamide protocol).", "interactions": "Interacted with L-arginine (beneficial) and L-NAME (aggravating effects).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:03.766139+00:00"}
{"study_id": 5197, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's role in cytoprotection, organoprotection, and stress coping, as well as its therapeutic potential in wound healing, vascular protection, and mitigating cancer cachexia.", "results_summary": "BPC-157 demonstrated protective effects on gastric mucosa, endothelium, and multiple organs, improved blood flow integrity, and counteracted muscle wasting and pro-inflammatory cytokines in cancer cachexia. It also showed efficacy in wound healing and vascular recruitment.", "population_specificity": "Not specified (likely preclinical models based on described effects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:05.120036+00:00"}
{"study_id": 5198, "supplement_id": 948, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to critically review the literature on BPC-157 as a feasible therapy for healing and functional restoration of soft tissue damage, focusing on tendon, ligament, and skeletal muscle healing.", "results_summary": "Studies demonstrated consistently positive and prompt healing effects for various injury types, including traumatic and systemic injuries, across multiple soft tissues. However, most studies were conducted on small rodent models, and human efficacy remains unconfirmed.", "population_specificity": "Small rodent models (majority), with potential implications for humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:05.223921+00:00"}
{"study_id": 5201, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's role in cytoprotection and adaptive cytoprotection against alcohol-induced lesions in the stomach and other gastrointestinal tissues.", "results_summary": "BPC-157 effectively cured alcohol-induced lesions, enhanced mucosal protection, and restored sphincter pressures, outperforming NO-system agents like L-arginine and L-NAME.", "population_specificity": "Not specified (animal model implied by dosage units).", "effective_dosage": "0.01 mg/kg and 0.00001 mg/kg (intraperitoneal).", "study_duration": "Immediate post-alcohol administration (timing: 1 min to 24 h).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:10.741335+00:00"}
{"study_id": 5200, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine if BPC-157 can attenuate duodenal lesions caused by major venous occlusions, independent of nitric oxide system involvement.", "results_summary": "BPC-157 significantly reduced mucosal lesions and serosal congestion, improved vessel presentation, and normalized oxidative stress markers (NO and MDA) in duodenal tissues. It also enhanced vascular interconnections and branching by over 60%, bypassing the occlusion effectively.", "population_specificity": "Male Wistar rats with induced superior anterior pancreaticoduodenal vein (SAPDV) ligation.", "effective_dosage": "10 \u03bcg/kg and 10 ng/kg per 1 mL bath/rat, or 10 \u03bcg/kg instilled into the stomach.", "study_duration": "Treatment administered at 1 min post-ligation, with observations up to 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:11.065538+00:00"}
{"study_id": 5199, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract liver fibrosis and portal hypertension in rats with bile duct ligation (BDL).", "results_summary": "BPC-157 therapy normalized oxidative stress markers (MDA, NO), reduced liver damage markers (AST, ALT, GGT, ALP, bilirubin), and improved liver histology (reduced necrosis, inflammation, fibrosis). It also mitigated portal hypertension and systemic symptoms like jaundice and ascites.", "population_specificity": "Rats with bile duct ligation (BDL).", "effective_dosage": "10 \u03bcg/kg or 10 ng/kg continuously in drinking water (0.16 \u03bcg/ml or 0.16 ng/ml, 12 ml/rat/day); intraperitoneal administration at 30 min post-ligation and 24 h before sacrifice; local bath BPC 157 (10 \u03bcg/kg) for portal hypertension.", "study_duration": "Up to 8 weeks (intervention started immediately post-surgery or at week 4).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:11.263022+00:00"}
{"study_id": 5204, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of BPC-157 in controlling Nosema ceranae infections and improving honeybee colony health.", "results_summary": "BPC-157 supplementation increased honeybee colony strength and reduced N. ceranae spore loads, while also attenuating midgut damage in infected honeybees.", "population_specificity": "Honeybee colonies infected with Nosema ceranae.", "effective_dosage": "0.1 \u03bcg/ml BPC-157 in 0.25 L sugar syrup.", "study_duration": "21 consecutive days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:11.625682+00:00"}
{"study_id": 5203, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to demonstrate BPC-157's cytoprotective effects, particularly its ability to protect cells and endothelium outside the stomach, and its role in controlling blood vessel function in response to injury or obstruction.", "results_summary": "BPC-157 showed significant cytoprotective effects, including healing organ lesions, preventing and reversing thrombosis, and restoring blood flow by activating blood vessels near defects or obstructions. It also counteracted adverse effects of L-NAME and L-arginine.", "population_specificity": "Not specified (abstract does not detail human or animal subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:11.842003+00:00"}
{"study_id": 5202, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of using Lactococcus lactis as a delivery vector for BPC-157 to reduce reactive oxygen species (ROS) production and treat gastrointestinal inflammation.", "results_summary": "The study found that BPC-157 delivered via L. lactis significantly decreased ROS production in a fibroblast cell model, with secretion being more effective (117 ng/ml) than surface display (30 ng/ml). The AcmA/Usp45-fusion protein showed superior surface display ability for BPC-157.", "population_specificity": "149BR fibroblast cell model", "effective_dosage": "30 ng/ml (surface display), 117 ng/ml (secretion)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:11.885292+00:00"}
{"study_id": 5205, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the adverse effects of inferior caval vein ligation in rats, including thrombosis, hemodynamic changes, and tissue damage.", "results_summary": "BPC-157 effectively counteracted vein injury, thrombosis, and hemodynamic disturbances, promoted collateral circulation, normalized NO and MDA levels, and modulated gene expression related to vascular function.", "population_specificity": "Rats with induced inferior caval vein ligation.", "effective_dosage": "10 \u03bcg, 10 ng/kg (early or delayed therapy).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:13.108650+00:00"}
{"study_id": 5206, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of BPC-157 on colitis and ischemia-reperfusion injury in rats, focusing on its ability to restore blood supply and counteract oxidative stress.", "results_summary": "BPC-157 improved vessel presentation, reduced oxidative stress markers (MDA and NO), preserved mucosal integrity, and counteracted adverse effects induced by L-NAME and L-arginine. It also promoted tissue recovery in obstructed colon segments.", "population_specificity": "Rats with induced colitis, ischemia-reperfusion injury, or colon obstruction.", "effective_dosage": "10 \u03bcg/kg (bath application, 1 mL/rat).", "study_duration": "Acute effects observed within 15 minutes; long-term effects assessed up to 10 days.", "interactions": "Counteracted effects of L-NAME and L-arginine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:15.435825+00:00"}
{"study_id": 5207, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract celecoxib-induced toxicity and assess its interaction with the NO system.", "results_summary": "BPC-157 effectively counteracted celecoxib-induced gastrointestinal, liver, and brain lesions, as well as mitigated the negative effects of NO system blockade (L-NAME). It showed consistent benefits across all tested dosages and time points (24h and 48h).", "population_specificity": "Rats", "effective_dosage": "10 \u03bcg/kg, 10 ng/kg, or 1 ng/kg (intraperitoneal)", "study_duration": "24h and 48h post-intervention", "interactions": "Celecoxib, L-arginine, L-NAME", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:19.875396+00:00"}
{"study_id": 5208, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract cyclophosphamide-induced stomach and duodenal ulcers and oxidative stress in rats, as well as its interaction with the NO-system.", "results_summary": "BPC-157 attenuated increased NO- and MDA-levels, nullified severe cyclophosphamide-induced ulcers, and counteracted lesions exacerbated by L-NAME, suggesting its protective role against oxidative and ulcerative damage.", "population_specificity": "Rats treated with cyclophosphamide and L-NAME.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg intraperitoneally once a day or in drinking water.", "study_duration": "Until sacrifice (up to 7 days).", "interactions": "Cyclophosphamide, L-NAME, and L-arginine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:20.368782+00:00"}
{"study_id": 5209, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to demonstrate BPC-157's role as an integrative mediator in stress response and its organoprotective effects across various tissues, including gastrointestinal and extragastrointestinal systems.", "results_summary": "BPC-157 showed significant healing effects in gastrointestinal and extragastrointestinal tissues, counteracted dopamine-system dysfunction, and interacted with serotonin and GABA systems. It also demonstrated cytoprotection, adaptive organoprotection, and beneficial effects on lesions, wounds, and blood disturbances.", "population_specificity": "Not specified (clinical trials referenced but details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Counteracted complications of L-NAME and L-arginine applications.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:20.711026+00:00"}
{"study_id": 5210, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could counteract magnesium toxicity and its effects on cell depolarization in rats, potentially through NO-system-related mechanisms.", "results_summary": "BPC-157 effectively counteracted hypermagnesemia and magnesium-induced disturbances, including muscle weakness, lesions, and hyperkalaemia, while also inhibiting cell depolarization in vitro. L-NAME and L-arginine worsened magnesium toxicity, but their combined use with BPC-157 restored control values.", "population_specificity": "Rats", "effective_dosage": "10 \u00b5g or 10 ng intraperitoneally, administered once before magnesium injection", "study_duration": "30-minute observation period post-intervention", "interactions": "L-NAME and L-arginine worsened magnesium toxicity, but BPC-157 opposed these effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:21.279319+00:00"}
{"study_id": 5211, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the adverse effects of esophagogastric anastomosis in rats, particularly by addressing NO-system dysfunction and improving healing outcomes.", "results_summary": "BPC-157 (all regimens) effectively counteracted disease progression, preserved blood vessels, eliminated mortality, and nullified the worsening effects of L-NAME. It also enhanced the benefits of L-arginine, demonstrating a strong therapeutic effect on anastomosis healing and sphincter function.", "population_specificity": "Rats with esophagogastric anastomosis and esophagocutaneous fistulas.", "effective_dosage": "10 \u03bcg or 10 ng/kg intraperitoneally once daily, or in drinking water.", "study_duration": "4 days", "interactions": "Interacted with L-NAME (NOS-blocker) and L-arginine (NOS substrate), enhancing or counteracting their effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:21.844710+00:00"}
{"study_id": 5213, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of BPC-157 as a novel mediator in brain-gut axis interactions and its therapeutic effects on CNS disorders, GI tract, and tissue healing.", "results_summary": "BPC-157 demonstrated strong antiulcer potency, neuroprotective effects, and beneficial impacts on various behavioral disturbances by modulating serotonergic and dopaminergic systems. It also promoted healing in GI tract, liver, pancreas, and various tissues, and attenuated injuries from NSAIDs, insulin overdose, or encephalopathies.", "population_specificity": "Primarily animal models (rats) and human trials in inflammatory bowel disease and multiple sclerosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:22.043190+00:00"}
{"study_id": 5212, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157, alone or combined with L-arginine, could counteract the adverse effects of diclofenac and nitric oxide system blockade on wound healing and organ damage in rats following massive small bowel resection.", "results_summary": "BPC-157 significantly improved anastomosis healing, reduced gastrointestinal, liver, and brain lesions, and counteracted the worsening effects of diclofenac and L-NAME. L-arginine partially ameliorated L-NAME-induced aggravation but was less effective than BPC-157.", "population_specificity": "Short-bowel rats following massive small bowel resection.", "effective_dosage": "BPC-157 (10 \u03bcg/kg or 10 ng/kg), administered intraperitoneally.", "study_duration": "Immediate post-surgery intervention, assessed 24 hours later.", "interactions": "Diclofenac and L-NAME worsened symptoms, while L-arginine partially counteracted L-NAME effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:22.516060+00:00"}
{"study_id": 5214, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could heal rectovaginal fistulas in rats, based on its known effects on external fistulas.", "results_summary": "BPC-157, administered orally or intraperitoneally, significantly improved healing of rectovaginal fistulas in rats, reducing defects, leakage, and complications like adhesions and intestinal obstruction. Both microgram and nanogram regimens showed rapid and complete healing.", "population_specificity": "Rats with surgically induced rectovaginal fistulas.", "effective_dosage": "10\u03bcg/kg or 10ng/kg, administered perorally in drinking water (0.16\u03bcg/ml or 0.16ng/ml, 12ml/rat/day) or intraperitoneally.", "study_duration": "Treatment continued until sacrifice, with assessments at days 1, 3, 5, 7, 10, 14, and 21.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:25.695084+00:00"}
{"study_id": 5215, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could heal duodenocutaneous fistulas in rats and assess its interaction with the nitric oxide system.", "results_summary": "BPC-157 fully counteracted persistent defects, fistula leakage, and sphincter failure in rats, achieving rapid improvement and complete healing. It also nullified the worsening effects of L-NAME and enhanced the benefits of L-arginine.", "population_specificity": "Rats with duodenocutaneous fistulas.", "effective_dosage": "10 \u03bcg/kg or 10 ng/kg, intraperitoneally or perorally (in drinking water).", "study_duration": "21 days.", "interactions": "L-NAME (nitric oxide synthase inhibitor) and L-arginine (nitric oxide synthase substrate).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:29.992411+00:00"}
{"study_id": 5221, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's safety, efficacy in treating gastrointestinal disorders (particularly IBD), and its wound-healing and angiogenic effects.", "results_summary": "BPC-157 demonstrated a strong safety profile with no reported side effects, efficacy in treating IBD and promoting wound healing, and interaction with the NO-system for endothelium protection and angiogenesis.", "population_specificity": "Patients with inflammatory bowel disease (IBD) and conditions involving impaired wound healing.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:30.495358+00:00"}
{"study_id": 5220, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic effects of BPC-157 on esophagocutaneous fistulas in rats, particularly its interaction with the NO-system and comparison with L-NAME and l-arginine.", "results_summary": "BPC-157 accelerated fistula healing, reduced leakage, and restored sphincter pressure, counteracting L-NAME effects. It was effective in both \u03bcg- and ng-regimens, administered perorally or intraperitoneally, with no mortality reported by day 4.", "population_specificity": "Rats with established cervical esophagocutaneous fistulas.", "effective_dosage": "\u03bcg- and ng-regimens (specific amounts not detailed).", "study_duration": "4 days.", "interactions": "Counteracted effects of L-NAME (NOS-blocker) and worked synergistically with l-arginine (NO-substrate).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:31.591653+00:00"}
{"study_id": 5217, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract inflammatory bowel disease (colitis) and multiple sclerosis (cuprizone-induced nerve damage) in rat models.", "results_summary": "BPC-157 effectively promoted healing in colitis and colon-colon anastomosis models and reduced nerve damage in cuprizone-induced multiple sclerosis, particularly in severely affected brain areas. It also improved cerebellar ataxia and forelimb function.", "population_specificity": "Rat models of colitis and multiple sclerosis (cuprizone-induced nerve damage).", "effective_dosage": "10 \u03bcg/kg or 10 ng/kg intraperitoneally or intragastrically; 0.16 \u03bcg/ml or 0.16 ng/ml in drinking water.", "study_duration": "Varied by model (e.g., until sacrifice at day 4 for cuprizone, up to day 14 for colon-colon anastomosis).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:31.596952+00:00"}
{"study_id": 5216, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate BPC-157's effects on hemostasis, particularly its ability to counteract bleeding and thrombocytopenia induced by L-NAME and L-arginine in rats with tail amputation and anticoagulant administration.", "results_summary": "BPC-157 consistently reduced bleeding time and hemorrhage while counteracting thrombocytopenia in rats, even when combined with L-NAME or L-arginine. It also rescued hemostatic mechanisms disrupted by anticoagulants like heparin and warfarin.", "population_specificity": "Rats with tail amputation, some treated with heparin or warfarin.", "effective_dosage": "10 \u03bcg/kg, 10 ng/kg (i.p., i.v. for heparin); 10 \u03bcg/kg (i.g. for warfarin).", "study_duration": "3 days for warfarin administration; other interventions were acute.", "interactions": "Counteracted effects of L-NAME (thrombocytopenia) and L-arginine (increased hemorrhage).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:31.986985+00:00"}
{"study_id": 5218, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could improve leak point pressure (LPP) recovery in rat models of stress urinary incontinence (SUI) following transabdominal urethrolysis (TU) and prolonged vaginal dilatation (VD).", "results_summary": "BPC-157 counteracted the decrease in LPP values in TU and VD rats, restoring LPP to levels seen in healthy rats. Immunohistochemical analysis showed improved muscle organization, angiogenesis, and preserved tissue structure in treated rats.", "population_specificity": "Rats with induced SUI via TU or VD, and healthy rats as controls.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg intraperitoneally once daily; 10 \u00b5g/kg orally in drinking water (0.16 \u00b5g/mL, 12 mL/rat/day).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:32.207739+00:00"}
{"study_id": 5222, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could counteract esophagitis, sphincter failure, and acute pancreatitis by addressing their common causative mechanisms.", "results_summary": "BPC-157 effectively counteracted esophagitis, sphincter failure, and acute pancreatitis in rats, demonstrating therapeutic potential for these conditions. The study also found that these conditions aggravate each other when combined, but BPC-157 mitigated these effects.", "population_specificity": "Rats and acute pancreatitis patients (for esophageal manometry).", "effective_dosage": "10 \u03bcg/kg and 10 ng/kg, administered intraperitoneally or in drinking water.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:34.485991+00:00"}
{"study_id": 5224, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could effectively counteract the gastrointestinal, liver, and brain toxicity induced by diclofenac in rats.", "results_summary": "BPC-157 strongly antagonized diclofenac toxicity, preventing severe gastric, intestinal, and liver lesions, reducing elevated bilirubin and liver enzymes, and mitigating brain edema and neuronal damage. The peptide was effective both intraperitoneally and orally at microgram and nanogram doses.", "population_specificity": "Rats exposed to diclofenac toxicity.", "effective_dosage": "10 \u03bcg/kg and 10 ng/kg intraperitoneally; 0.16 \u03bcg/mL and 0.16 ng/mL orally in drinking water.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:39.200964+00:00"}
{"study_id": 5223, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate BPC-157's therapeutic potential for gastrointestinal and other organ lesions, including its effects on healing, inflammation, and sphincter function.", "results_summary": "BPC-157 demonstrated significant healing effects on gastrointestinal lesions, improved sphincter function, and exhibited angiogenic, neuroprotective, and anti-inflammatory properties. It also reversed alcohol- and NSAID-induced damage and promoted fistula closure even with delayed treatment.", "population_specificity": "Rats with induced gastrointestinal and organ lesions.", "effective_dosage": "Not specified", "study_duration": "Varied (e.g., up to one month for fistula closure, 4 weeks for short-bowel syndrome)", "interactions": "Interacts with the NO-system, dopamine, 5-HT system, and endothelin.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:39.275227+00:00"}
{"study_id": 5226, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could reduce thrombus formation and improve functional recovery after aortic termino-terminal anastomosis in rats.", "results_summary": "BPC-157 (10 \u00b5g/kg) reduced thrombus formation, preserved walking ability, and restored muscle strength when administered immediately after anastomosis or intraperitoneally at 24 hours. No thrombus was observed at the anastomosis site in treated rats.", "population_specificity": "Albino male rats with aortic termino-terminal anastomosis.", "effective_dosage": "10 \u00b5g/kg, administered as a bath immediately after anastomosis or intraperitoneally at 24 hours.", "study_duration": "24 hours post-anastomosis.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:39.965744+00:00"}
{"study_id": 5228, "supplement_id": 948, "safety_score": "80", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to determine whether BPC-157 could counteract the adverse effects of insulin overdose, including gastric ulcers, seizures, liver damage, and hypoglycemia in rats.", "results_summary": "BPC-157 effectively prevented fatal outcomes, reduced seizures, minimized liver pathology, preserved glycogen levels, decreased serum enzyme levels, and reduced brain neuron damage in insulin-overdosed rats.", "population_specificity": "Rats subjected to insulin overdose (250 IU/kg i.p.).", "effective_dosage": "10 \u00b5g/kg, administered intraperitoneally or intragastrically immediately after insulin.", "study_duration": "Observations made up to 180 minutes post-insulin overdose.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:40.495123+00:00"}
{"study_id": 5225, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to investigate BPC-157's effectiveness in counteracting liver and brain damage caused by extreme paracetamol overdose in rats, focusing on both prophylactic and therapeutic applications.", "results_summary": "BPC-157 effectively prevented convulsions (prophylactic use) or rapidly resolved them (therapeutic use), reduced liver and brain lesions, and lowered enzyme and ammonium serum levels, demonstrating strong antidote potential against paracetamol toxicity.", "population_specificity": "Rats subjected to extreme paracetamol overdose (5 g/kg intraperitoneally).", "effective_dosage": "10 \u00b5g, 10 ng, or 10 pg/kg, administered intraperitoneally or intragastrically.", "study_duration": "Intervention effects observed over a 3-24 hour post-paracetamol period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:40.999975+00:00"}
{"study_id": 5227, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of BPC-157 on inflammation and bone resorption in experimental periodontitis in rats.", "results_summary": "BPC-157 significantly reduced plasma extravasation, histological signs of inflammation, and alveolar bone resorption in rats with ligature-induced periodontitis, but had no effect on gingivomucosal blood flow in healthy gingiva.", "population_specificity": "Rats with experimentally induced periodontitis.", "effective_dosage": "Once daily for 12 days (specific dosage not provided).", "study_duration": "12 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:41.185074+00:00"}
{"study_id": 5229, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 improves healing of medial collateral ligament (MCL) injuries in rats through various administration routes.", "results_summary": "BPC-157 improved MCL healing in rats when administered intraperitoneally, orally, or topically, demonstrating consistent functional, biomechanical, macroscopic, and histological improvements. The peptide was effective at microgram and nanogram doses without a carrier.", "population_specificity": "Rats with surgically transected MCL.", "effective_dosage": "Intraperitoneal (10 \u00b5g or 10 ng/kg once daily), topical (1.0 \u00b5g dissolved in cream/g), oral (0.16 \u00b5g/ml in drinking water, 12 ml/day/rat).", "study_duration": "Up to 90 days post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:44.223066+00:00"}
{"study_id": 5230, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether BPC-157 could improve muscle healing in rats with muscle crush injuries and counteract corticosteroid-induced impairment.", "results_summary": "BPC-157 accelerated muscle healing and restored full function, even in the presence of corticosteroid treatment, as demonstrated functionally, macroscopically, and histologically. It completely reversed corticosteroid-impaired muscle healing.", "population_specificity": "Rats with injured gastrocnemius muscle complex", "effective_dosage": "Not specified (given intraperitoneally or locally as a cream, once immediately after injury or once daily)", "study_duration": "Up to 14 days", "interactions": "Counteracted corticosteroid (6\u03b1-methylprednisolone) impairment", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:47.547457+00:00"}
{"study_id": 5231, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether BPC-157 improves healing and functional recovery in rats with transected sciatic nerves.", "results_summary": "BPC-157 significantly enhanced nerve regeneration, evidenced by improved histomorphometric, electrophysiological, and functional outcomes, including faster axonal regeneration, increased motor action potentials, and improved walking recovery. Autotomy was absent in treated rats.", "population_specificity": "Rats with transected sciatic nerves.", "effective_dosage": "10 \u00b5g, 10 ng/kg (intraperitoneally, intragastrically, or locally).", "study_duration": "One or two months post-injury.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:47.614498+00:00"}
{"study_id": 5233, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether BPC-157 could effectively treat short bowel syndrome in rats by promoting intestinal healing and weight recovery.", "results_summary": "BPC-157 administration (both orally and intraperitoneally) led to immediate weight gain, improved intestinal structure (villus height, crypt depth, muscle thickness), normalized jejunal and ileal diameters, and increased anastomosis strength in rats with short bowel syndrome.", "population_specificity": "Rats with induced short bowel syndrome via small bowel resection.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg, administered daily in drinking water (12 ml/rat/day) or intraperitoneally.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:49.361506+00:00"}
{"study_id": 5235, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 accelerates healing in crushed muscle injuries and transected tendons, and its potential clinical relevance for muscle crush injuries.", "results_summary": "BPC-157 improved muscle healing macroscopically (reduced hematoma and edema, no leg contracture), microscopically, functionally, and via enzyme activity markers, with effectiveness both locally and intraperitoneally.", "population_specificity": "Crushed rats (gastrocnemius muscle complex injury).", "effective_dosage": "Applied intraperitoneally or locally as a thin cream layer immediately after injury and once daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:49.710746+00:00"}
{"study_id": 5232, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could prevent and counteract digitalis-induced arrhythmias in rats, particularly through its interaction with the NO-system.", "results_summary": "BPC-157 reduced ventricular premature beats, prolonged the onset of ventricular tachycardia, and mitigated AV-block duration in digitalis-challenged rats. It also showed prophylactic and therapeutic efficacy, with higher doses preventing fatal outcomes and lower doses delaying them.", "population_specificity": "Rats with digitalis-induced arrhythmias.", "effective_dosage": "50 \u00b5g, 10 \u00b5g, and 10 ng/kg (intravenous and intraperitoneal).", "study_duration": "Immediate to short-term (e.g., 20 seconds post-AV-block for therapeutic intervention).", "interactions": "Interaction with the NO-system (L-NAME and L-arginine effects noted).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:49.751244+00:00"}
{"study_id": 5234, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic effect of BPC-157 on persistent colocutaneous fistula healing in rats and its relationship with nitric oxide (NO) modulation.", "results_summary": "BPC-157 accelerated healing of colonic and skin defects, improved fistula closure, and maintained functionality, even with blunted NO generation. L-NAME worsened healing, while L-arginine was only effective with blunted NO. BPC-157's benefits remained consistent regardless of NO modulation.", "population_specificity": "Rats with surgically induced colocutaneous fistulas.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg, administered either in drinking water or once daily intraperitoneally.", "study_duration": "Up to 28 days post-surgery.", "interactions": "Interactions noted with L-NAME, L-arginine, sulphasalazine, and 6-alpha-methylprednisolone.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:51.025870+00:00"}
{"study_id": 5236, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 is more effective than standard agents in healing gastrocutaneous fistulas and persistent gastric ulcers, particularly under corticosteroid aggravation.", "results_summary": "BPC-157 demonstrated superior healing effects on both skin and stomach mucosa, even after corticosteroid aggravation, compared to standard anti-ulcer agents. It improved fistula closure and prevented leakage, while standard agents showed delayed and limited efficacy.", "population_specificity": "Rats with surgically induced gastrocutaneous fistulas.", "effective_dosage": "10 \u00b5g/kg in drinking water (12 ml/rat/day) or intraperitoneally (10 \u00b5g/kg, 10 ng/kg, 10 pg/kg).", "study_duration": "Up to 21 days post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:53.740419+00:00"}
{"study_id": 5237, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of BPC-157 and methylprednisolone on early functional recovery and inflammation in a rat model of Achilles tendon-to-bone transection.", "results_summary": "BPC-157 improved functional recovery by reducing inflammation (lower myeloperoxidase activity and inflammatory cell influx) and promoting new blood vessel formation, while methylprednisolone reduced inflammation but hindered blood vessel formation and did not improve functional recovery.", "population_specificity": "Male Wistar Albino rats with surgically transected Achilles tendons.", "effective_dosage": "10 \u00b5g/kg BPC-157, administered intraperitoneally once daily.", "study_duration": "1-4 days post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:56.569509+00:00"}
{"study_id": 5238, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could alleviate esophagitis and improve sphincter pressure in rats with induced sphincter failure.", "results_summary": "BPC-157 treatment alleviated esophagitis and normalized pressure in both the pyloric and lower esophageal sphincters, while ranitidine had no effect. In normal rats, BPC-157 increased lower esophageal sphincter pressure but decreased pyloric sphincter pressure.", "population_specificity": "Rats with induced sphincter failure and esophagitis, as well as normal rats.", "effective_dosage": "10 \u00b5g/kg or 10 ng/kg intraperitoneally once daily; 0.16 \u00b5g/ml or 0.16 ng/ml continuously in drinking water (12 ml/rat per day); or direct stomach administration before pressure assessment.", "study_duration": "Treatment lasted until 24 hours before assessment, with follow-up at 7 days, 14 days, or 12 months post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:58.566154+00:00"}
{"study_id": 5240, "supplement_id": 948, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could improve healing and functional restoration in completely transected quadriceps muscle and Achilles tendon in rats.", "results_summary": "BPC-157 consistently improved muscle healing, including biomechanical strength, functional recovery, microscopic regeneration, and macroscopic presentation, with no reported toxicity. The peptide restored near-normal muscle structure and function over a 72-day period.", "population_specificity": "Rats with completely transected quadriceps muscle and Achilles tendon.", "effective_dosage": "10 \u00b5g, 10 ng, or 10 pg/kg intraperitoneally, once daily.", "study_duration": "72 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:58.736610+00:00"}
{"study_id": 5241, "supplement_id": 948, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate BPC-157's effects on serotonin syndrome in rats, specifically its ability to counteract symptoms induced by MAO-inhibition and serotonin precursor administration.", "results_summary": "BPC-157 significantly reduced serotonin syndrome symptoms, including hyperthermia and wet dog shakes, particularly counteracting 5-HT2A receptor-related disturbances. It showed efficacy at various doses, with higher doses counteracting milder symptoms.", "population_specificity": "Rats with induced serotonin syndrome via pargyline (MAO-inhibitor) and L-tryptophan (serotonin precursor).", "effective_dosage": "10 \u00b5g, 10 ng, 10 pg/kg intraperitoneally.", "study_duration": "Not specified in the abstract.", "interactions": "Counteracted effects of pargyline and L-tryptophan; no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:06:59.543561+00:00"}
{"study_id": 5239, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 could effectively treat prolonged esophagitis and recover failed sphincters in a rat model.", "results_summary": "BPC-157 treatment recovered esophagitis (macroscopically and microscopically) and restored pressure in both lower esophageal and pyloric sphincters, while ranitidine had no effect. The peptide's effects were specific, increasing lower esophageal sphincter pressure in normal rats but decreasing pyloric sphincter pressure.", "population_specificity": "Rats with prolonged esophagitis and sphincter failure.", "effective_dosage": "10 \u00b5g/kg intraperitoneally once daily or 0.16 \u00b5g/ml continuously in drinking water (12 ml/rat).", "study_duration": "Treatment lasted until 24 hours before assessment; initial challenges were evaluated at 12 or 20 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:00.141367+00:00"}
{"study_id": 5242, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 improves healing of CO(2) laser injuries in mice and assess its effectiveness when applied topically.", "results_summary": "BPC-157 consistently improved healing of CO(2) laser injuries in mice, both macroscopically and microscopically, with the most effective dosage being 1 microg/g in neutral cream. The peptide demonstrated favorable stability and effectiveness without requiring a carrier.", "population_specificity": "Male NMRI-Hannover mice with CO(2) laser-induced dorsal skin injuries.", "effective_dosage": "1 microg, 1 ng, or 1 pg BPC-157 per gram of neutral cream, applied topically once daily.", "study_duration": "Treatment lasted up to 21 days, with the first application 60 minutes post-injury and the last 24 hours before euthanasia.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:01.272401+00:00"}
{"study_id": 5243, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To investigate the protective effects of BPC-157 on acute and chronic gastric ulcers in rats and compare its efficacy via different administration methods (intramuscular vs. intragastric).", "results_summary": "Both intramuscular and intragastric administration of BPC-157 reduced ulcer area and accelerated healing, with intramuscular administration showing superior efficacy. Higher dosages (400 ng/kg, 800 ng/kg) significantly reduced lesions, and continuous application improved glandular epithelium regeneration and granulation tissue formation.", "population_specificity": "Rats with induced acute and chronic gastric ulcers.", "effective_dosage": "200 ng/kg, 400 ng/kg, and 800 ng/kg (single or continuous administration).", "study_duration": "Not specified (acute and chronic models used).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:03.072856+00:00"}
{"study_id": 5244, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether BPC-157 improves healing in transected Achilles tendons in rats and its potential mechanisms of action.", "results_summary": "BPC-157 significantly improved tendon healing biomechanically, functionally, microscopically, and macroscopically, with enhanced recovery of tendon integrity and opposition to negative growth modulators like HNE.", "population_specificity": "Rats with transected Achilles tendons.", "effective_dosage": "10 \u00b5g, 10 ng, or 10 pg/kg body weight, administered intraperitoneally once daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:04.554674+00:00"}
{"study_id": 5219, "supplement_id": 948, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate BPC-157's ability to counteract hyperkalemia-induced effects, including arrhythmias, muscular weakness, and sphincter dysfunction, and its interaction with the NO-system.", "results_summary": "BPC-157 effectively counteracted hyperkalemia-induced disturbances, restored normal sinus rhythm, and nullified lesions, with no additive effect when combined with l-arginine. It also directly affected potassium conductance in vitro.", "population_specificity": "Animal models (in vivo) and HEK293 cells (in vitro).", "effective_dosage": "10ng, 10\u03bcg (intraperitoneal and intragastric).", "study_duration": "Single-dose administration (30min before or 10min after KCl).", "interactions": "Combined with l-arginine, but no additive effect noted. L-NAME aggravated outcomes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:07.140549+00:00"}
{"study_id": 181529, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to explore the potential of BPC-157 as a therapeutic peptide for enhancing recovery, tissue repair, and performance optimization in high-level athletes and bodybuilders.", "results_summary": "Early in vivo research suggests BPC-157 may optimize endurance training, metabolism, recovery, and tissue repair, but clinical evidence in orthopedic applications remains scarce. The abstract highlights the growing interest in therapeutic peptides despite limited literature on clinical outcomes.", "population_specificity": "High-level athletes and bodybuilders.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:07.325975+00:00"}
{"study_id": 5245, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if BPC-157 could counteract corticosteroid-impaired healing in thermally injured mice and assess its effects on burn healing and burn-gastric lesions.", "results_summary": "BPC-157 improved burn healing, counteracted corticosteroid-impaired healing, exhibited anti-ulcer effects, and reversed corticosteroid-induced immunosuppression in mice.", "population_specificity": "Male NMRI-Hannover mice with thermal injuries.", "effective_dosage": "BPC-157 cream at three different levels (1 microg/g cream mentioned for in vitro assessment).", "study_duration": "Treatment lasted up to 21 days, with daily applications.", "interactions": "Counteracted effects of 6alpha-methylprednisolone.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:07.534949+00:00"}
{"study_id": 5490, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the feasibility of intracranial lead reconstruction in DBS therapy for Parkinsonism and assess its association with clinical outcomes.", "results_summary": "Patients showed postoperative improvements in Hoehn-Yahr stage, UPDRS \u2162 score, SE-ADL score, and LEDD, but only those with bilateral stimulating contacts in the STN maintained improvements at 12 months. Lead reconstruction and standard programming selected matching optimal contacts 77.78% of the time.", "population_specificity": "27 patients with Parkinson's disease who received bilateral STN DBS therapy.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:08.536169+00:00"}
{"study_id": 5246, "supplement_id": 948, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of BPC-157, administered topically or systemically, on burn healing and gastric lesions in burned mice.", "results_summary": "BPC-157 improved burn healing parameters, reduced inflammation and necrosis, enhanced collagen formation, and attenuated gastric lesions in burned mice, outperforming controls and silver sulfadiazine.", "population_specificity": "Mice with deep partial skin thickness burns covering 20% of total body area.", "effective_dosage": "10 \u00b5g or 10 ng/kg intraperitoneally; topically as 50 \u00b5g, 5 \u00b5g, 500 ng, 50 ng, or 5 ng mixed in cream.", "study_duration": "Daily until 24 hours before sacrifice (up to 21 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:09.283494+00:00"}
{"study_id": 5491, "supplement_id": 949, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess whether pulvinar hypointensity in susceptibility-weighted imaging (SWI) could predict cognitive worsening in Parkinson's disease patients after deep brain stimulation (DBS).", "results_summary": "Pulvinar hypointensity in SWI was observed in 11 of 21 patients at baseline, with five of six patients showing cognitive decline post-DBS exhibiting this feature. Hallucinations were reported in six patients, all of whom had pulvinar hypointensity, while those without it had no hallucinations.", "population_specificity": "21 patients with Parkinson's disease who underwent DBS.", "effective_dosage": "Not specified", "study_duration": "1 year postoperatively", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:10.143822+00:00"}
{"study_id": 5492, "supplement_id": 949, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety, efficacy, and suitability of deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) for treating movement disorders, particularly in older patients with comorbidities.", "results_summary": "The study found that DBS is effective but carries surgical risks like hemorrhage and infections, while MRgFUS is less invasive with fewer complications but has irreversible side effects. Both techniques require careful patient selection and consideration of risks versus benefits.", "population_specificity": "Patients with movement disorders, particularly older individuals with higher comorbidities.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:11.421812+00:00"}
{"study_id": 5495, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop an interactive, patient-specific computational model to simulate the effects of deep brain stimulation (DBS) using MRI and DWI data, enabling real-time adjustments to electrode position and stimulation settings.", "results_summary": "The study developed a novel image processing pipeline that allows for near real-time simulation of DBS effects, including current steering with multiple leads, reducing the burden of computational modeling for non-experts while providing meaningful feedback on electrode position and stimulation configurations.", "population_specificity": "Not specified (focused on computational modeling rather than a clinical population)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:13.226185+00:00"}
{"study_id": 5497, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore advancements in deep brain stimulation (DBS), focusing on target structures and adaptive stimulation techniques using neural and behavioral feedback signals.", "results_summary": "The study highlights DBS as an established therapy for neurological disorders, particularly movement disorders, and discusses recent research on target structures and adaptive DBS techniques. It outlines future directions for improving DBS efficacy and adaptability.", "population_specificity": "Patients with neurological disorders, particularly movement disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:16.533720+00:00"}
{"study_id": 5499, "supplement_id": 949, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to analyze hardware-related complications and causes of unnatural death in Parkinson's disease patients treated with deep brain stimulation (DBS).", "results_summary": "The study found high survival rates (98.6% at 3 years, 96.4% at 5 years) among DBS-treated PD patients, with pneumonia being the most frequent cause of death. Hardware-related complications occurred in 4.6% of patients, and prophylactic measures were used to reduce infection risk.", "population_specificity": "478 patients with advanced Parkinson's disease experiencing motor fluctuations and medication-refractory tremor.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:16.830981+00:00"}
{"study_id": 5496, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to formulate suggestions for a preoperative evaluation protocol for surgical treatment of Parkinson's disease, including eligibility criteria and target selection for deep brain stimulation (DBS).", "results_summary": "The study proposed criteria for surgical eligibility and emphasized the need for dedicated DBS teams. It also discussed the pros and cons of targeting the subthalamic nucleus versus the globus pallidus internus for DBS.", "population_specificity": "Patients with Parkinson's disease presenting with motor complications or medically-refractory disabling tremor.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:16.878249+00:00"}
{"study_id": 5498, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether deep brain stimulation (DBS) affects emotional attentional processing in Parkinson's disease (PD) patients, comparing it to healthy aging and other movement disorder groups.", "results_summary": "PD patients showed overall worse performance but maintained intact emotional attentional capture, suggesting that fear recognition deficits in PD are specific to recognition rather than general emotional processing. STN-DBS did not significantly alter emotional attentional capture compared to other groups.", "population_specificity": "PD patients (n=20), healthy elderly (n=20), young adults (n=18), and Essential Tremor patients (n=18) undergoing VIM-DBS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:16.974453+00:00"}
{"study_id": 5500, "supplement_id": 949, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness, safety, and current applications of deep brain stimulation (DBS) for Parkinson's disease patients with motor fluctuations, medication-resistant tremor, and/or dyskinesia.", "results_summary": "DBS is effective for managing motor symptoms in Parkinson's disease, with the subthalamic nucleus and globus pallidus internus being common targets. Current research focuses on improving symptom control, developing new technologies, and optimizing stimulation delivery, including personalized and adaptive approaches like closed-loop systems.", "population_specificity": "Parkinson's disease patients experiencing motor fluctuations, medication-resistant tremor, and/or dyskinesia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:17.945951+00:00"}
{"study_id": 5501, "supplement_id": 949, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review the current status, mechanisms, surgical techniques, patient selection, and clinical outcomes of deep brain stimulation (DBS) for movement disorders, as well as recent advancements.", "results_summary": "DBS has shown consistent success in clinical trials for movement disorders like Parkinson's disease, essential tremor, and dystonia, but it has limitations and well-recognized complications, requiring careful patient selection. Advances in surgical techniques and technology have improved its application.", "population_specificity": "Patients with medication-refractory Parkinson's disease, essential tremor, and dystonia.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:19.084507+00:00"}
{"study_id": 5502, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential mechanisms of transcranial direct current stimulation (tDCS) in addressing central post-stroke pain (CPSP) and propose a new model based on interhemispheric inhibition theory.", "results_summary": "The study reviewed potential mechanisms of tDCS for CPSP and reported two cases where tDCS was used to address CPSP, suggesting it may help restore interhemispheric balance and alleviate pain.", "population_specificity": "Patients with central post-stroke pain (CPSP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:20.131167+00:00"}
{"study_id": 5503, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the therapeutic potential of explanting and reimplanting DBS leads in a non-responsive OCD patient to determine if targeting a different brain region could improve outcomes.", "results_summary": "The study found that reimplanting DBS leads in the ventral capsule-ventral striatum region improved symptoms in a previously non-responsive OCD patient, suggesting reversibility and adaptability of DBS therapy in resistant cases.", "population_specificity": "A 22-year-old male with extremely severe, treatment-refractory OCD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:21.763851+00:00"}
{"study_id": 5508, "supplement_id": 949, "safety_score": "60", "efficacy_score": 70, "quality_score": 40, "study_goal": "The researchers aimed to demonstrate the movement of DBS leads due to brain shift and their ability to return to the original position after correction.", "results_summary": "The study found that despite an acute subdural hematoma displacing DBS leads, the leads returned near their original position post-evacuation, and six months of stimulation therapy achieved a 50% reduction in Parkinson's symptoms.", "population_specificity": "A 57-year-old man with a 21-year history of Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:24.934747+00:00"}
{"study_id": 5506, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a predictive model for optimizing combined pharmacologic-deep brain stimulation (DBS) therapy outcomes in Parkinson's disease patients.", "results_summary": "The study found that a linear function incorporating DBS parameters, levodopa dosage, and patient-specific preoperative data could predict motor outcomes (r = 0.76; p < 0.05), suggesting potential for personalized treatment optimization.", "population_specificity": "6 advanced Parkinson's disease patients.", "effective_dosage": "Not specified (levodopa dosage was included as a variable but exact amounts not detailed).", "study_duration": "Not specified (60 follow-up visits, but duration per patient not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:25.211268+00:00"}
{"study_id": 5507, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the application of non-invasive brain stimulation (NIBS) techniques\u2014tDCS, rTMS, iTBS, and ECT\u2014in treating symptoms of multiple sclerosis (MS).", "results_summary": "ECT showed efficacy for severe psychiatric disorders in case reports, while tDCS and TMS yielded mixed results for depressive symptoms, fatigue, sensory deficits, pain, motor performance, and spasticity. Overall, data on NIBS for MS treatment remains sparse.", "population_specificity": "Multiple sclerosis (MS) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:25.351606+00:00"}
{"study_id": 5509, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Parkinson's disease (PD) patients exhibit deficits in multi-joint proprioception and whether subthalamic nucleus deep brain stimulation (STN DBS) improves this proprioceptive function.", "results_summary": "PD patients showed significant proprioceptive localization errors and variability with STN DBS off, which were partially normalized with visual feedback. STN DBS reduced localization errors without vision but increased variability.", "population_specificity": "Twelve PD patients with bilateral STN DBS implants and 12 age-matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:25.411249+00:00"}
{"study_id": 5511, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the impact of deep brain stimulation (DBS) on voice parameters in patients with Parkinson's disease (PD).", "results_summary": "The study found that DBS improved nearly all acoustic analysis parameters during phonation, with jitter being the most sensitive to both surgical and medical therapy. Fundamental frequency increased under levodopa treatment, while jitter and shimmer decreased post-treatment.", "population_specificity": "25 patients with advanced Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "One week and one month after DBS electrode implant.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:25.938258+00:00"}
{"study_id": 5512, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of deep brain stimulation (DBS) as a surgical treatment option for refractory Tourette's syndrome, focusing on its reversibility and modularity compared to other interventions.", "results_summary": "The abstract suggests that DBS is currently preferred for refractory Tourette's syndrome due to its reversibility and modularity, but highlights unresolved issues regarding treatment indication, target selection, and follow-up evaluation.", "population_specificity": "Patients with refractory Tourette's syndrome unresponsive to conservative or nonsurgical treatments.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:27.197006+00:00"}
{"study_id": 5513, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the outcomes of frameless versus frame-based deep brain stimulation (DBS) surgery in patients with Parkinson's disease.", "results_summary": "Frameless DBS surgery showed similar clinical motor function improvement (60.9% vs. 56.9%) compared to frame-based surgery after 12 months, but with shorter microelectrode recording time and fewer trajectories.", "population_specificity": "24 patients with advanced Parkinson's disease (12 in each group).", "effective_dosage": "Not specified", "study_duration": "Follow-up for at least 12 months post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:29.772167+00:00"}
{"study_id": 5515, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of deep brain stimulation (DBS) therapy in helping vegetative state (VS) patients emerge from their condition and assess long-term outcomes.", "results_summary": "Eight of 21 VS patients emerged from their vegetative state and could obey verbal commands after DBS therapy, though most remained bedridden. The study suggests DBS may be useful for VS patients if selected based on neurophysiological criteria, and highlights the need for specialized neurorehabilitation.", "population_specificity": "Twenty-one vegetative state (VS) patients with brain damage, followed for over 10 years.", "effective_dosage": "Not specified", "study_duration": "Follow-up over 10 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:30.528537+00:00"}
{"study_id": 5520, "supplement_id": 949, "safety_score": "80", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of a novel deep brain stimulation (DBS) method using two parallel electrodes to improve tremor control in essential tremor patients.", "results_summary": "The study found that traditional single-electrode DBS could not completely stop the patient's tremor without adverse effects, but the new dual-electrode method achieved complete tremor abolition without adverse effects. This suggests improved efficacy and safety with the new approach.", "population_specificity": "A patient with unilateral severe essential tremor.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:33.038824+00:00"}
{"study_id": 5518, "supplement_id": 949, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of deep brain stimulation (DBS) therapy in treating various involuntary movement disorders.", "results_summary": "DBS therapy significantly improved symptoms of movement disorders, with Vim stimulation best for tremor, GPi or STN stimulation effective for rigidity and bradykinesia, and GPi stimulation useful for dystonia in young patients. The study also noted DBS's advantage over ablative procedures due to its non-destructive nature.", "population_specificity": "110 patients with various types of involuntary movements.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:33.394004+00:00"}
{"study_id": 5516, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of deep brain stimulation of the bilateral globus pallidus internus (DBS B-GPi) in treating primary generalized dystonia (PGD) associated with the DYT1 gene.", "results_summary": "The study found that DBS B-GPi successfully reduced debilitating motor abnormalities in a DYT1-positive 13-year-old boy with PGD, where pharmacological treatments had previously failed. The intervention demonstrated clinically meaningful improvements in motor function.", "population_specificity": "A 13-year-old boy with DYT1-positive primary generalized dystonia (PGD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:33.656551+00:00"}
{"study_id": 5521, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical applications, advantages, and future potential of deep brain stimulation (DBS) therapy for neurological disorders.", "results_summary": "DBS was found effective for controlling intractable pain and involuntary movements, with advantages over conventional neuroablative therapies, including reversibility, controllability, and potential neural plasticity effects. Further integration with neuromonitoring devices could expand its therapeutic applications.", "population_specificity": "Patients with neurological disorders, including those with intractable pain and involuntary movements.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:34.016375+00:00"}
{"study_id": 5519, "supplement_id": 949, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness of deep brain stimulation (DBS) therapy in helping patients emerge from a persistent vegetative state (PVS) and identify neurophysiological criteria for selecting suitable candidates.", "results_summary": "Seven out of twenty PVS patients emerged from the vegetative state and could obey verbal commands after DBS therapy, though they remained bedridden. The responders showed specific EEG and evoked potential patterns, suggesting neurophysiological markers may predict treatment success.", "population_specificity": "Twenty patients in a persistent vegetative state (PVS) caused by various brain injuries.", "effective_dosage": "Not specified", "study_duration": "Evaluated at 3 months after persistence of PVS; intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:34.113455+00:00"}
{"study_id": 4770, "supplement_id": 950, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of L. plantarum LM1001 to enhance protein digestion and utilization, particularly focusing on branched-chain amino acids (Ile, Leu, and Val) in whey protein.", "results_summary": "L. plantarum LM1001 increased concentrations of branched-chain amino acids and promoted myotube formation in C2C12 myotubes by upregulating myogenic regulatory factors (Myf-5, MyoD, myogenin). The strain also exhibited \u03b2-galactosidase activity without producing harmful \u03b2-glucuronidase.", "population_specificity": "C2C12 myotubes (in vitro study)", "effective_dosage": "Whey protein culture supernatant (1%, 2%, and 3%, v/v)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:36.531451+00:00"}
{"study_id": 4771, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the relationship between branched-chain amino acids (BCAAs) and liver diseases, including their role in disease progression and potential therapeutic effects.", "results_summary": "The study found that BCAA levels vary in different liver diseases, with clinical research showing mixed results on the efficacy of BCAA supplementation for cirrhosis and liver cancer. The mechanisms underlying these changes remain complex and not fully understood.", "population_specificity": "Patients with liver diseases, including non-alcoholic fatty liver disease, hepatocellular carcinoma, cirrhosis, hepatic encephalopathy, hepatitis C virus infection, and acute liver failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:38.765966+00:00"}
{"study_id": 4772, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the association between branched-chain amino acids (BCAAs) and sarcopenia, and assess whether muscle mass mediates the relationship between BCAAs and muscle strength.", "results_summary": "The study found positive associations between BCAAs (total BCAA, isoleucine, leucine, valine) and muscle mass/strength, with valine linked to a 47% reduced sarcopenia risk. Muscle mass was identified as a mediator in the BCAA-muscle strength relationship.", "population_specificity": "108,017 UK adults (mean age 56.40 \u00b1 8.09 years; 46.23% men)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:39.609617+00:00"}
{"study_id": 4773, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a multifactorial intervention including branched-chain amino acids could improve frailty in outpatients with cirrhosis.", "results_summary": "The intervention group showed significant improvement in frailty (measured by LFI) and reduced incidence of falls and emergency room visits compared to the control group. The study concluded that branched-chain amino acids, combined with exercise and probiotics, effectively improved frailty and clinical outcomes.", "population_specificity": "Outpatients with cirrhosis classified as prefrail or frail.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:41.319598+00:00"}
{"study_id": 4774, "supplement_id": 950, "safety_score": "30", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to study the reaction kinetics and byproduct formation of branched-chain amino acids (BCAAs) when exposed to hypochlorite in water treatment conditions.", "results_summary": "The study found that BCAAs react with hypochlorite to form harmful chlorinated byproducts such as chloroform, chloroacetaldehyde, and nitriles under both neutral and alkaline conditions, potentially deteriorating water quality.", "population_specificity": "Not applicable (in vitro chemical study)", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:41.390564+00:00"}
{"study_id": 4776, "supplement_id": 950, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the efficacy, tolerability, and safety of varying doses of oral BCAA supplementation in concussed adolescents and young adults.", "results_summary": "The study found no significant difference in processing speed (primary outcome) but observed a dose-response reduction in total symptom scores and improved return to physical activity with higher BCAA doses. No serious adverse events were reported, with only mild to moderate adverse events noted, primarily gastrointestinal.", "population_specificity": "Concussed adolescents and young adults (ages 11-34).", "effective_dosage": "15 g, 30 g, 45 g, and 54 g BCAA daily, plus placebo.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:43.001257+00:00"}
{"study_id": 4777, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the therapeutic effect of THCQ on T2DM-associated MAFLD, focusing on its role in BCAA catabolism and hepatic steatosis.", "results_summary": "THCQ improved hepatic steatosis by upregulating fatty acid oxidation and reducing synthesis via PPAR\u03b1/\u03b3 pathways, mediated through enhanced BCAA catabolism in skeletal muscles. Knockdown of BCKDHA diminished THCQ's therapeutic effect, highlighting the role of BCAA metabolism.", "population_specificity": "High-fat diet/STZ-induced T2DM mice", "effective_dosage": "2.5 g/kg or 5 g/kg THCQ", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:43.064307+00:00"}
{"study_id": 4775, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of adrenal disorders on branched-chain amino acids (BCAAs) and their association with adverse cardiometabolic disorders and mortality.", "results_summary": "The study found increased BCAAs in patients with nonfunctioning adenomas (NFA), mild autonomous cortisol secretion (MACS), Cushing syndrome (CS), primary aldosteronism (PA), and adrenocortical carcinoma (ACC), suggesting an association with adverse metabolic profiles.", "population_specificity": "Patients with adrenal disorders (NFAs, MACS, PA, CS, PPGLs, other benign/malignant adrenal masses, ACC) and referent individuals from the PREVEND study.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:43.454527+00:00"}
{"study_id": 4778, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of branched-chain amino acids (BCAAs) in gut microbiota dysbiosis and their impact on ulcerative colitis symptoms.", "results_summary": "The study found that BCAAs exacerbated ulcerative colitis symptoms by mediating the mTOR/p70S6K signaling pathway, while bergenin reduced BCAA levels and improved gut microbiota balance.", "population_specificity": "DSS-induced colitis mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:44.230117+00:00"}
{"study_id": 4780, "supplement_id": 950, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the in vitro effects of branched-chain amino acids (BCAA) on LPS-induced inflammatory responses in Caco-2 cells, focusing on their potential anti-inflammatory properties.", "results_summary": "BCAA supplementation did not impair cell viability. Leucine and isoleucine attenuated LPS-induced IL-8 synthesis and JNK/NF-kB phosphorylation, demonstrating anti-inflammatory effects, while valine and high BCAA showed no significant impact on glutathione-related markers.", "population_specificity": "Caco-2 cells (human intestinal epithelial cell line)", "effective_dosage": "0.8 mM (normal BCAA), 2 mM (individual amino acids or high BCAA)", "study_duration": "24 hours before LPS stimulation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:48.929253+00:00"}
{"study_id": 4783, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to update the current understanding of the roles of BCAAs and their metabolism in the development and progression of cardiovascular diseases (CVDs).", "results_summary": "High levels of circulating BCAAs are associated with an increased risk of CVDs, but the causal relationship and underlying mechanisms remain poorly understood. The study discusses potential strategies targeting BCAA nutrition and metabolism for CVD prevention and treatment.", "population_specificity": "General (clinical and animal studies referenced, no specific human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:50.716168+00:00"}
{"study_id": 4782, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine how dietary fat quality affects plasma branched-chain amino acids (BCAAs) in men with the PNPLA3 rs738409 variant, and whether genotype influences these effects.", "results_summary": "The study found that total plasma BCAAs changed in the average diet group based on PNPLA3 genotype, with valine decreasing in the recommended diet group and leucine decreasing in the average diet group. The PNPLA3 genotype modified the effect of dietary fat on BCAA levels.", "population_specificity": "88 men (age 67.8 \u00b1 4.3 years, BMI 27.1 \u00b1 2.5 kg/m\u00b2) homozygous for the PNPLA3 rs738409 variant.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:50.774022+00:00"}
{"study_id": 4786, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the connection between disrupted branched-chain amino acids (BCAAs) metabolism and heart failure progression, as well as assess the potential of modulating BCAAs metabolism as a treatment.", "results_summary": "The study found that disrupted BCAAs metabolism is linked to heart failure progression and cardiovascular diseases like hypertension and obesity. It also highlighted BCAAs and their metabolites as potential biomarkers for cardiac metabolic risk and discussed therapeutic strategies targeting BCAAs metabolism.", "population_specificity": "Patients with cardiovascular diseases, particularly heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:52.089901+00:00"}
{"study_id": 4781, "supplement_id": 950, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between branched-chain amino acids (BCAAs) and triglyceride metabolism, and their role in the development of cardiovascular disease (CVD) through the mTOR/SREBP-1/betatrophin pathway.", "results_summary": "The study found that higher BCAA levels were associated with increased prevalence and incidence of T2DM, NAFLD, and CVD risk. In animal and in vitro models, BCAA accumulation elevated triglyceride levels and betatrophin expression, promoting myocardial fibrosis, but these effects were reversible with inhibitors or siRNAs.", "population_specificity": "1302 human subjects and a hyperbranched-chain aminoacidemia rat model induced by a high fructose diet.", "effective_dosage": "0.1-5 mM BCAAs in vitro.", "study_duration": "4-5 years for human subjects; duration for animal model not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:52.112013+00:00"}
{"study_id": 4785, "supplement_id": 950, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the efficacy of perioperative BCAA supplementation in reducing postoperative complications and improving outcomes in liver cancer patients undergoing surgery.", "results_summary": "Perioperative BCAA administration reduced postoperative infection, ascites, and length of hospital stay while increasing body weight, with no significant differences in mortality, cancer recurrence, or overall survival. No significant safety concerns were identified.", "population_specificity": "Liver cancer patients undergoing surgical resection or liver transplantation.", "effective_dosage": "Not specified", "study_duration": "Perioperative (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:52.763422+00:00"}
{"study_id": 4784, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the nutritional and functional properties of a yeast protein isolate (YPI), particularly its content of essential amino acids (EAAs) and branched-chain amino acids (BCAAs), compared to plant-based protein alternatives.", "results_summary": "The study found that YPI contained 18.4 g of BCAAs per 100 g protein, surpassing plant-based protein isolates. YPI also demonstrated superior water- and oil-holding capacities, emulsion stabilization, and foaming properties compared to pea, whey, and soy protein isolates.", "population_specificity": "Not specified (in vitro or food industry application implied).", "effective_dosage": "Not specified (optimized extraction: 4 cycles of HPH at 100 MPa).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:54.181994+00:00"}
{"study_id": 4787, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the protective effects of a low-branched chain amino acid (BCAA) diet in a mouse model of heart failure and its impact on histone acylation and cardiac stress response.", "results_summary": "The study found that a low-BCAA diet had a protective effect against heart failure in mice, implicating histone H3 lysine 23 propionylation (H3K23Pr) in transcriptional control of the cardiac stress response. The results suggest that dietary and pharmacological interventions targeting BCAA metabolism could decelerate cardiac hypertrophy.", "population_specificity": "Mouse model of heart failure", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:57.803637+00:00"}
{"study_id": 4789, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the hypothetical link between BCAA metabolism, insulin resistance, T2DM, and its microvascular complications.", "results_summary": "The study discusses the association of BCAAs with insulin resistance and diabetes development, suggesting potential for novel biomarkers or therapeutic concepts, but does not present definitive clinical outcomes.", "population_specificity": "General discussion on T2DM and its complications, not a specific study population.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:58.988688+00:00"}
{"study_id": 4788, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of branched-chain amino acids (BCAAs) in managing advanced chronic liver disease (ACLD), focusing on their impact on nutritional deficiencies and associated complications.", "results_summary": "The study highlights the pivotal role of BCAAs in ACLD management, particularly in addressing low Fischer's ratio and improving nutritional status, though the evidence on outcomes is critically evaluated rather than conclusively proven.", "population_specificity": "Patients with advanced chronic liver disease (ACLD), including both decompensated and compensated cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:07:59.348206+00:00"}
{"study_id": 4791, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the dual role of BCAAs in tumorigenesis, including their potential to inhibit tumor growth or promote metastasis depending on conditions and concentrations.", "results_summary": "The study found that BCAAs can inhibit tumor growth at high concentrations but may promote metastasis when deficient. Their effects on cancer cells involve influencing adhesion, angiogenesis, and macromolecule synthesis.", "population_specificity": "Human malignancies (various types, not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:00.623508+00:00"}
{"study_id": 4792, "supplement_id": 950, "safety_score": "60", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of Branched-Chain Amino Acids (BCAAs) in megakaryocyte differentiation and platelet production, and whether BCAA catabolism affects thrombocytopoiesis.", "results_summary": "The study found that BCAA diet facilitated megakaryocyte differentiation and platelet production, while deficiency in BCAA catabolism led to thrombocythemia. Activating BCAA metabolism with BT2 inhibited mTOR signaling and ameliorated thrombocythemia in BCAA-fed mice.", "population_specificity": "Mice (BCAA-fed mice and megakaryocyte/platelet-specific branched-chain \u03b1-keto acid dehydrogenase E1\u03b1 subunit-deficient mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:02.158275+00:00"}
{"study_id": 4793, "supplement_id": 950, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining EPA and BCAA in different ratios could improve muscle mass, strength, and inflammatory biomarkers in elderly individuals with inadequate protein intake.", "results_summary": "The study found that consuming a nutrition drink fortified with EPA and BCAA (2:1:1 or 4:1:1 Leu:Ile:Val) significantly increased right arm muscle mass and handgrip strength, with trends suggesting improved muscle protein synthesis and anti-inflammatory effects.", "population_specificity": "Elderly individuals with inadequate protein intake.", "effective_dosage": "2.2 g EPA + 5 g BCAA (2:1:1 or 4:1:1 Leu:Ile:Val) daily.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:03.359163+00:00"}
{"study_id": 4794, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Branched-Chain Amino Acids (BCAA) intake correlates with total lymphocyte count (TLC) in head and neck cancer patients.", "results_summary": "The study found no strong correlation between BCAA intake and TLC (r = 0.235, p = 0.056) in head and neck cancer patients. The contribution of non-BCAA amino acids to lymphocyte proliferation was suggested for further investigation.", "population_specificity": "Head and neck cancer patients (mostly male, aged 18-75) who had not received treatment.", "effective_dosage": "Mean BCAA intake was 10.92 \u00b1 0.48 g/day.", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:07.501247+00:00"}
{"study_id": 4795, "supplement_id": 950, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the potential benefits of BCAA supplementation in improving behavioral symptoms in children with autism.", "results_summary": "The study found that 47.27% of children who took BCAA for more than 10 weeks showed improvements in social behavior, speech, cooperation, stereotypy, and hyperactivity, with no reported adverse reactions.", "population_specificity": "Children aged 6-18 with autistic behavior.", "effective_dosage": "0.4 g/kg of body weight daily, administered as a powdered mixture containing 45.5 g leucine, 30 g isoleucine, and 24.5 g valine.", "study_duration": "Varied, with some children continuing beyond 10 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:08.421675+00:00"}
{"study_id": 4796, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the molecular mechanisms by which Branched-Chain Amino Acids (BCAAs) regulate skeletal muscle growth and protein metabolism in common carp under starvation and refeeding conditions.", "results_summary": "The study identified key genes (e.g., atg5, map1lc3c) and miRNAs (e.g., miR-135c, miR-192) involved in muscle growth, protein synthesis, and catabolism, suggesting BCAAs play a regulatory role in these processes. Transcriptome and miRNA analyses revealed enriched pathways like proteasome and autophagy, indicating BCAA's potential in modulating muscle protein deposition.", "population_specificity": "Common carp (fish species)", "effective_dosage": "Not specified", "study_duration": "14-day starvation followed by 14-day BCAA gavage therapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:09.993889+00:00"}
{"study_id": 4797, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of 16-week BCAA supplementation on frailty, muscle mass, and quality of life in frail compensated cirrhotic patients.", "results_summary": "BCAA supplementation significantly improved frailty (measured by LFI), BMI, serum albumin, skeletal muscle index, and physical quality of life domains compared to the control group, with 36% achieving frailty reversion versus 0% in controls.", "population_specificity": "Frail compensated cirrhotic patients (Child-Pugh A/B, mean age 65.5 years, 51.9% female).", "effective_dosage": "Twice daily (210 kcal, protein 13.5 g, BCAA 2.03 g per dose).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:10.425070+00:00"}
{"study_id": 4779, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of branched-chain amino acids (BCAA) and their ketoacids (BCKA) on production performance and liver triglyceride accumulation in postpartum Holstein cows.", "results_summary": "BCAA supplementation improved milk production (yield, fat, and lactose), while BCKA supplementation reduced liver triglyceride accumulation. No differences were observed in body weight, body condition score, or dry matter intake.", "population_specificity": "Multiparous Holstein cows in the first 3 weeks postpartum.", "effective_dosage": "BCAA (67 g valine, 50 g leucine, 34 g isoleucine daily); BCKA (77 g 2-ketovaline calcium salt, 57 g 2-ketoleucine calcium salt, 39 g 2-ketoisoleucine calcium salt daily).", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:11.180372+00:00"}
{"study_id": 4799, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the regulatory effects and mechanisms of branched-chain amino acids (BCAAs) and their metabolic intermediates on insulin resistance and type 2 diabetes.", "results_summary": "Elevated BCAA levels are linked to insulin resistance and type 2 diabetes, affecting insulin signaling via mTOR activation and disrupting lipid metabolism. Some BCAA metabolites worsen insulin resistance, while \u03b2-aminoisobutyric acid may improve it by reducing lipid accumulation and inflammation.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:11.468229+00:00"}
{"study_id": 4790, "supplement_id": 950, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of BCAA supplementation on survival, tumor recurrence, and other clinical outcomes in patients undergoing hepatic interventions for liver diseases.", "results_summary": "BCAA supplementation did not significantly affect tumor recurrence or overall survival but improved liver function (increased serum albumin and cholinesterase levels), reduced ascites incidence, and increased body weight and arm circumference.", "population_specificity": "Patients undergoing hepatectomy, trans-arterial embolization, or radiofrequency ablation for liver diseases.", "effective_dosage": "Not specified", "study_duration": "Outcomes measured at 6 and 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:11.540198+00:00"}
{"study_id": 4798, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether long-term dietary intake of branched-chain amino acids (BCAA) is associated with liver-related mortality in patients with advanced fibrosis or compensated cirrhosis.", "results_summary": "The study found no significant association between BCAA intake and liver-related death, transplantation, hepatocellular carcinoma, encephalopathy, or clinical hepatic decompensation in HCV-infected patients with advanced fibrosis or compensated cirrhosis.", "population_specificity": "North American patients with advanced fibrosis or compensated cirrhosis from the HALT-C Trial.", "effective_dosage": "BCAA intake ranged from 3.0 to 34.8 g per 1000 kcal of energy intake.", "study_duration": "Median follow-up of 5.0 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:11.835053+00:00"}
{"study_id": 4801, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine if BCAA plus vitamin D supplementation could reduce muscle mass and strength loss, improve functional mobility, and enhance clinical outcomes in older adults after lumbar surgery for LSS.", "results_summary": "BCAA plus vitamin D did not improve clinical outcomes (ZCQ scores) but significantly increased knee extensor and flexor strength at 12 weeks compared to the control group. No differences were observed in muscle mass, gait speed, or TUG.", "population_specificity": "Older adults (80 patients) who underwent lumbar surgery for lumbar spinal stenosis (LSS).", "effective_dosage": "Twice daily for 3 weeks (specific BCAA dosage not stated).", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:18.034339+00:00"}
{"study_id": 4804, "supplement_id": 950, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review the role of BCAA and HMB supplementation in liver cirrhosis, focusing on nutritional and clinical effects.", "results_summary": "BCAA supplementation slightly increased muscle mass and BMI, improved hepatic encephalopathy symptoms, and showed no change in fat mass. HMB's effects on muscle mass in liver cirrhosis remain unclear.", "population_specificity": "Patients with liver cirrhosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:18.291373+00:00"}
{"study_id": 4800, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of branched-chain amino acids (BCAAs) on the production of perylenequinones in Shiraia mycelium cultures, focusing on their role in fungal secondary metabolism.", "results_summary": "L-Valine (L-Val) at 1.5 g/L significantly increased perylenequinone production, including hypocrellin A (HA), while L-leucine (L-Leu) suppressed it. L-Val also upregulated key genes involved in perylenequinone biosynthesis and central carbon metabolism.", "population_specificity": "Shiraia mycelium cultures (fungal model).", "effective_dosage": "1.5 g/L for L-Val and L-Leu.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:18.432973+00:00"}
{"study_id": 4802, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine how Branched-Chain Amino Acids (BCAAs) affect CD8+ T cell functions and their potential role in enhancing anti-tumor immunity.", "results_summary": "The study found that BCAA accumulation in CD8+ T cells leads to hyper-activity, increased glucose metabolism, and enhanced anti-tumor immunity. BCAA supplementation synergized with anti-PD-1 therapy, correlating with better prognosis in NSCLC patients.", "population_specificity": "PP2Cm-deficient mice and NSCLC patients receiving anti-PD-1 therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with anti-PD-1 therapy noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:18.853170+00:00"}
{"study_id": 4806, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the protective effects of BCAA on glucose metabolism disorders induced surgically in a rat model and explore the underlying mechanism.", "results_summary": "BCAA significantly reduced glycemia by suppressing liver gluconeogenesis via reduction of CRTC2 and G6PC gene and protein expression levels, without significant elevation of plasma insulin levels.", "population_specificity": "Rats undergoing surgical intervention", "effective_dosage": "3 mL load by gavage two hours before surgery", "study_duration": "Single dose administered preoperatively", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:19.368162+00:00"}
{"study_id": 4803, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate whether germinated brown rice (GBR) intervention affects branched-chain amino acids (BCAAs) metabolism in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "GBR intervention reduced fasting blood glucose, fasting insulin, and serum BCAAs while improving islet function. The study also found that key enzymes promoting BCAAs decomposition and glycolysis activation were significantly increased.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) (GBR group: n=42, Control group: n=25).", "effective_dosage": "100 g/day of germinated brown rice (GBR).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:19.785630+00:00"}
{"study_id": 4805, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the metabolic regulation of fibrosis and the role of branched-chain amino acids (BCAAs) in hepatic, renal, and cardiac fibrosis, with a focus on liver fibrosis and hepatocellular carcinoma.", "results_summary": "The study found that dysregulation of BCAAs metabolism contributes to fibrosis and reviewed the effects and mechanisms of BCAAs intervention in fibrosis, highlighting their potential therapeutic targeting in liver, kidney, and heart fibrosis.", "population_specificity": "Not specified (review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:19.912425+00:00"}
{"study_id": 4807, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether grape polyphenol extract supplementation could counteract the metabolic effects of overfeeding, particularly on branched-chain amino acids (BCAA) levels.", "results_summary": "Polyphenol supplementation counterbalanced the increase in BCAA levels induced by overfeeding, with consistent findings in both male and female studies. The extract showed a protective metabolic effect against overfeeding.", "population_specificity": "Normal weight to overweight male adults (Lyon study) and females (Lausanne study).", "effective_dosage": "2 g/day grape polyphenol extract.", "study_duration": "31 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:20.779633+00:00"}
{"study_id": 4808, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the relationship between circadian rhythm and BCAA metabolism during fasting, and whether circadian rhythm regulates BCAA metabolism to maintain physiological homeostasis.", "results_summary": "The study found that fasting dynamically coordinates transcription between circadian rhythm and BCAA metabolic pathways, with Clock regulating KLF15 expression, which in turn promotes Bcat2 transcription to enhance BCAA metabolism, maintaining energy homeostasis.", "population_specificity": "Siniperca chuatsi (fish species)", "effective_dosage": "Not specified", "study_duration": "Short-term fasting (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:26.074447+00:00"}
{"study_id": 4810, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Branched-Chain Amino Acids (BCAAs) on complications, nutritional status, and liver function in patients with liver cirrhosis.", "results_summary": "BCAAs reduced the rate of complications in liver cirrhosis patients, improved albumin levels, and significantly ameliorated alanine transaminase and aspartate aminotransferase levels. Glucose levels were also increased in BCAA-treated patients.", "population_specificity": "Patients with liver cirrhosis (1080 participants across nine studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:26.943105+00:00"}
{"study_id": 4814, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of BCAA supplementation on gut microbiota and metabolic functions in a mouse model of metabolic-associated fatty liver disease (MAFLD).", "results_summary": "BCAA supplementation reduced body weight, liver lipid accumulation, and serum cholesterol levels while improving gut bacterial diversity and altering microbiota composition in mice fed a high-fat diet. It also counteracted elevated serum BCAA levels by stimulating BCKDH enzymatic activity.", "population_specificity": "C57BL/6J mice fed a high-fat diet.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:27.849033+00:00"}
{"study_id": 4813, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of BCAAs metabolic disorders in tumorigenesis and progression, focusing on their impact and potential diagnostic and therapeutic approaches for BCAAs-related cancers.", "results_summary": "The study found that BCAAs and their metabolites play a pivotal role in tumor metabolism reprogramming, influencing processes like cell growth, proliferation, migration, and invasion. It highlighted key proteins involved in BCAAs metabolism and suggested potential diagnostic and therapeutic strategies for BCAAs-related cancers.", "population_specificity": "Tumor phenotypes (multiple types, not specified further)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:28.387898+00:00"}
{"study_id": 4809, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a 6-week very-low calorie diet (VLCD) on fasting branched-chain amino acids (BCAAs) in overweight non-diabetic men and explore associations between circulating BCAAs and insulin resistance (IR).", "results_summary": "The study found that overweight individuals had higher plasma BCAA concentrations compared to normal-weight individuals, but a 6-week VLCD did not reduce BCAA levels despite significant weight loss and improved insulin sensitivity. No correlations were observed between BCAA levels and insulin resistance before or after the intervention.", "population_specificity": "Overweight (BMI 32.4 \u00b1 3 kg/m\u00b2) and normal-weight (BMI 24 \u00b1 3.1 kg/m\u00b2) non-diabetic men.", "effective_dosage": "Not applicable (study focused on dietary intervention, not BCAA supplementation).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:28.794282+00:00"}
{"study_id": 4815, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine how lifestyle intervention interacts with the association between circulating branched-chain amino acids (BCAAs) and type 2 diabetes (T2D) risk, and how BCAA concentrations change during the intervention.", "results_summary": "Elevated baseline BCAAs predicted T2D incidence in the control group but not in the intervention group. BCAA levels decreased during the first year in the whole cohort, and specific BCAA trajectories were associated with varying T2D risk, with lifestyle intervention modifying these associations.", "population_specificity": "Adults at risk of type 2 diabetes (intervention group n=198, control group n=196).", "effective_dosage": "Not specified", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:28.882596+00:00"}
{"study_id": 4812, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a high BCAA diet could serve as an intervention target for Parkinson's disease by modulating inflammation and improving motor/non-motor functions in a PD mouse model.", "results_summary": "The study found that a high BCAA diet attenuated inflammatory levels, reversed motor and non-motor dysfunctions, and reduced dopaminergic neuron impairment in rotenone-induced PD mice. The decrease in BCAAs during PD progression was linked to gut microbiota alterations.", "population_specificity": "Rotenone-induced Parkinson's disease mouse model.", "effective_dosage": "Not specified (referred to as \"high BCAA diet\").", "study_duration": "Intervention duration not explicitly stated (study assessed effects at 0, 3, and 4 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:29.920303+00:00"}
{"study_id": 4816, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the distinct metabolic features of Tregs in the tumor microenvironment, particularly focusing on the role of branched-chain amino acids (BCAAs), such as isoleucine, in modulating Treg function.", "results_summary": "The study found that isoleucine, a BCAA, appears to predominantly affect regulatory T cells (Tregs) rather than conventional T cells, suggesting a potential metabolic vulnerability in Tregs that could be targeted for anti-tumor immune responses. The review highlights the potential of targeting BCAA metabolism in Tregs as a rational approach for specific immunotherapy.", "population_specificity": "Not specified (focus on Tregs in the tumor microenvironment)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:30.363616+00:00"}
{"study_id": 4817, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if empagliflozin (EMPA) could ameliorate diabetic retinopathy (DR) by modulating branched-chain amino acid (BCAA) metabolism in diabetic retinas.", "results_summary": "EMPA reduced BCAA and BCKA accumulation in diabetic retinas, inhibited oxidative stress, apoptosis, and inflammation, and improved tight junction integrity, suggesting a protective role against DR.", "population_specificity": "Db/db mice (a model for type 2 diabetes mellitus).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Different periods (exact duration not specified in the abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:34.667258+00:00"}
{"study_id": 4820, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize current literature and assess the efficacy of BCAA supplementation in patients with liver cirrhosis.", "results_summary": "BCAA supplementation showed beneficial effects on muscle mass, plasma albumin concentration, and reduction in serious cirrhotic complications, but no significant effect on fat mass or mortality.", "population_specificity": "Patients with liver cirrhosis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:34.936693+00:00"}
{"study_id": 4819, "supplement_id": 950, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the feasibility and preliminary efficacy of dietary supplementation with branched-chain amino acids (BCAA) on sleep and cognition in Veterans with traumatic brain injury (TBI).", "results_summary": "BCAA supplementation significantly improved subjective insomnia symptoms and objective sleep measures (latency and wake after sleep onset) in Veterans with TBI, with high adherence and tolerability. The study suggests BCAA as a promising intervention for sleep disturbances in this population.", "population_specificity": "Veterans with traumatic brain injury (TBI).", "effective_dosage": "30 g, twice daily (b.i.d.).", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:36.466960+00:00"}
{"study_id": 4818, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether exercise-induced changes in BCAA concentrations differ between individuals with mtDNA haplogroups J or K and those with non-JK haplogroups, suggesting a link to respiratory chain activity.", "results_summary": "The study found that serum BCAA concentrations increased more in subjects with haplogroups J or K compared to non-JK haplogroups after endurance exercise, indicating potential differences in respiratory chain activity. Structural analysis suggested a variant in haplogroups J and K may impair complex III function.", "population_specificity": "Finnish male conscripts (N=633) undergoing military service.", "effective_dosage": "Not specified", "study_duration": "Duration of military service (exact length not specified, typically 6-12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:36.941018+00:00"}
{"study_id": 4822, "supplement_id": 950, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the mechanisms of altered BCAA catabolism and its role in various pathological conditions, as well as the potential benefits of correcting dysregulated BCAA metabolism.", "results_summary": "The study found that BCAA supplementation is beneficial in chronic liver and kidney disease and muscle wasting disorders, but dysregulated BCAA catabolism is linked to conditions like diabetes, heart failure, and cancer. Correcting this dysregulation may improve outcomes and prevent complications.", "population_specificity": "Chronic liver and kidney disease patients, muscle wasting disorders, and broader metabolic/disease states (e.g., diabetes, heart failure, cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:37.882929+00:00"}
{"study_id": 4821, "supplement_id": 950, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether Branched-Chain Amino Acids (BCAA) supplementation improves muscle mass in patients with cirrhosis and sarcopenia when combined with exercise, dietary counseling, and standard medical therapy.", "results_summary": "The study found no significant improvement in muscle mass (measured by SMI) or secondary outcomes (handgrip strength, gait speed, walk distance) in the BCAA group compared to placebo. Adverse events were minor and similar in both groups.", "population_specificity": "Patients with cirrhosis (Child-Pugh score < 10) and sarcopenia, predominantly male (66.6%), with viral (40%) or alcohol-related (31.7%) cirrhosis.", "effective_dosage": "12 g/day of BCAA orally.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:38.723823+00:00"}
{"study_id": 184125, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the benefits and drawbacks of calcium intake, particularly in the context of fortified foods and dietary supplements, focusing on concerns related to overconsumption.", "results_summary": "The abstract highlights concerns about overconsumption of calcium but does not provide specific findings on its effects. It suggests regulatory attention is needed to address potential risks.", "population_specificity": "U.S. population", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:08:46.109841+00:00"}
